<?xml version='1.0' encoding='UTF-8'?>
<!-- Created by Xince -->
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:cbds.com="http://cbds.com/20241231" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024">
  <link:schemaRef xlink:href="./cbds-20200331_taxonomy.zip/cbds-20200331_taxonomy/cbds-20200331.xsd" xlink:type="simple"/>
  <xbrli:context id="c">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:DavidTobiasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:BradHerrMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RobertTanksonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c4">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:CathyCarrollMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c5">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c6">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:TrevorReedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c7">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cbds.com:N2017StockPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c8">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RelatedPartiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c9">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RelatedPartiesAcquistionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c10">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:GKMPMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c11">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:AggregateTotalsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c12">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:OwnershipAxis">cbds.com:GKMPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:PresidentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c13">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:UnrelatedPartiesCancelledMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:UnrelatedPartiesIssuedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c15">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:AggregateTotalsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c16">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c17">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c18">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c19">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c21">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c22">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:OwnershipAxis">cbds.com:GKMPMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c23">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c24">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c25">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c26">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c27">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c28">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c29">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:IbudtenderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c32">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c33">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestiBudTenderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c34">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestiBudTenderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c35">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c36">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c37">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c38">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c39">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c40">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c41">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c42">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c43">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c44">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c45">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c46">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c47">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c48">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:DavidTobiasMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c49">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c50">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestiBudTenderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c51">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestiBudTenderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c52">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestGKManufacturingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c53">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestGKManufacturingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c54">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestGKManufacturingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c55">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestGKManufacturingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c56">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c57">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c58">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:IbudtenderIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c59">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c60">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c61">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:OfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c62">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c63">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c64">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RelatedPartiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c65">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c66">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c67">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:OfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c68">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c69">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:TrevorReedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c70">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c71">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:CathyCarrollMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c72">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c73">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c74">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RobertTanksonMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c75">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestiBudTenderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c76">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:ConsultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c77">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:BradHerrMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c78">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestiBudTenderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c79">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestGKManufacturingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c80">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RelatedPartiesAcquistionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c81">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cbds.com:NoncontrollingInterestGKManufacturingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c82">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:IbudtenderIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c83">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:AggregateTotalsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c84">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cbds.com:N2017StockPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c85">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:DavidTobiasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c86">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:ConsultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c87">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c88">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:BradHerrMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c89">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c90">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RobertTanksonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c91">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cbds.com:OfficersAndDirectorsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c92">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c93">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:CathyCarrollMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c94">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:TrevorReedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c95">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RelatedPartiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c96">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cbds.com:OfficersAndDirectorsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c97">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:RelatedPartiesAcquistionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c98">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:AggregateTotalsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c99">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cbds.com:OfficersAndDirectorsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c100">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cbds.com:OfficersAndDirectorsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c101">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cbds.com:OfficersAndDirectorsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c102">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cbds.com:OfficersAndDirectorsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c103">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c104">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:GKManufacturingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c105">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-08-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c106">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:UnrelatedPartiesCancelledMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c107">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:UnrelatedPartiesIssuedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c108">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:AggregateTotalsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c109">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:UnrelatedPartiesCancelledMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c110">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:UnrelatedPartiesIssuedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c111">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:AggregateTotalsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c112">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:GKMPMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c113">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cbds.com:LeaseArrangementsTypeAxis">cbds.com:WarehouseLeaseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c114">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c115">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cbds.com:LeaseArrangementsTypeAxis">cbds.com:LasVegasOfficeFacilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c116">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cbds.com:LeaseArrangementsTypeAxis">cbds.com:SanFranciscoOfficeFacilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c117">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="cbds.com:LeaseArrangementsTypeAxis">cbds.com:NewYorkOfficeFacilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c118">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:PresidentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:GKMPMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c119">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cbds.com:GKMPMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:VicePresidentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c120">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cbds.com:ConvertibleSeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c121">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c122">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cbds.com:ConvertibleSeriesAPreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c123">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c124">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cbds.com:Warrant1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2020-01-01</xbrli:startDate>
      <xbrli:endDate>2020-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c125">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c126">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c127">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-06-24</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c128">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c129">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:IbudtenderMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c130">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InternetDomainNamesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:CannabisSativaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c131">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c132">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:KPALMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cbds.com:PatentsAndTrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c133">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InternetDomainNamesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:CannabisSativaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c134">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:PrestocorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c135">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c136">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cbds.com:KPALMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cbds.com:PatentsAndTrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c137">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c138">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001360442</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2020-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="usd">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="usd1">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f" decimals="0" contextRef="c" unitRef="usd">42857.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <cbds.com:NatureOfBusinessPolicyTextBlock id="f1" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Nature of Business:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cannabis Sativa, Inc. (the &amp;#8220;Company,&amp;#8221;&#13;&amp;#8220;us&amp;#8221;, &amp;#8220;we&amp;#8221; or &amp;#8220;our&amp;#8221;) was incorporated as Ultra Sun Corp. under the laws of Nevada in November&#13;2004. &amp;#160;On November 13, 2013, we changed our name to Cannabis Sativa, Inc. &amp;#160;&amp;#160; We operate through several subsidiaries&#13;including PrestoCorp, Inc. (&amp;#8220;PrestoCorp&amp;#8221;), iBudtender, Inc. (&amp;#8220;iBudtender&amp;#8221;), Wild Earth Naturals, Inc. (&amp;#8220;Wild&#13;Earth&amp;#8221;), Kubby Patent and Licenses Limited Liability Company, (&amp;#8220;KPAL&amp;#8221;), Hi Brands, International, Inc. (&amp;#8220;Hi&#13;Brands&amp;#8221;), GK Manufacturing and Packaging, Inc. (&amp;#8220;GKMP&amp;#8221;), and Eden Holdings LLC (&amp;#8220;Eden&amp;#8221;). &amp;#160;PrestoCorp&#13;and GK Manufacturing are both 51% owned subsidiaries and iBudtender is a 50.1% owned subsidiary. Wild Earth, KPAL, Hi Brands, and&#13;Eden are wholly owned subsidiaries. Currently, PrestoCorp, GKMP and iBudtender are operating subsidiaries, although iBudtender&#13;is not currently generating any revenue. The Company is reviewing opportunities for business development relating to Wild Earth,&#13;KPAL, and Hi Brands. Eden is not operating and had no activity for the three months ended March 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our primary operations in the three months&#13;ended March 31, 2020 were through PrestoCorp, which provides telemedicine online referral services for customers desiring medical&#13;marijuana cards in states where medical marijuana has been legalized. GKMP commenced operations during the quarter ended March&#13;31, 2020. The Company is also actively seeking new business opportunities for acquisition and is continually reviewing opportunities&#13;for product and brand development through our Wild Earth, Hi Brands, and KPAL subsidiaries. iBudtender is also working to complete&#13;and commercialize an application (the iBudtender App) that will provide a convenient means for sharing information about cannabis&#13;products, patients and businesses.&lt;/p&gt;</cbds.com:NatureOfBusinessPolicyTextBlock>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f2" decimals="0" contextRef="c2" unitRef="usd">63342.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <dei:EntityFilerCategory id="f3" contextRef="c1">Non-accelerated Filer</dei:EntityFilerCategory>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f4" decimals="0" contextRef="c3" unitRef="usd">40476.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f5" decimals="0" contextRef="c4" unitRef="usd">42857.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <cbds.com:NoncontrollingInterestsPolicyTextBlock id="f6" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Non-controlling Interests:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Non-controlling interests are portions of entities&#13;included in the condensed consolidated financial statements that are not attributable to the Company. Non-controlling interest&#13;are identified separately from the Company&amp;#8217;s stockholders&amp;#8217; equity and its net income (loss). Non-controlling interest&#13;equity balances include the non-controlling entity&amp;#8217;s initial contribution at the date of the original acquisition, ongoing&#13;contributions, distributions, and percentage share of earnings since inception. The non-controlling interests are calculated based&#13;on percentages of ownership.&lt;/p&gt;</cbds.com:NoncontrollingInterestsPolicyTextBlock>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f7" decimals="0" contextRef="c5" unitRef="usd">1253.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f8" decimals="0" contextRef="c6" unitRef="usd">7142.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <cbds.com:Covid19TextBlock id="f9" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;8. &amp;#160;&amp;#160;COVID- 19:&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The outbreak of COVID-19, the coronavirus,&#13;has grown both in the United States and globally, and related government and private sector responsive actions have adversely affected&#13;the Company&amp;#8217;s business operations. The World Health Organization has declared Covid-19 to be a global pandemic, resulting&#13;in an economic downturn and changes in global economic policy that will reduce demand for the Company&amp;#8217;s products and may&#13;have an adverse impact on the Company&amp;#8217;s business, operating results and financial condition.&lt;/p&gt;</cbds.com:Covid19TextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized id="f10" decimals="INF" contextRef="c7" unitRef="shares">954720.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f11" decimals="0" contextRef="c8" unitRef="usd">196674.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <dei:EntitySmallBusiness id="f12" contextRef="c1">true</dei:EntitySmallBusiness>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f13" decimals="0" contextRef="c9" unitRef="usd">395401.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <cbds.com:NetRevenuesDescription id="f14" contextRef="c10">If GKMP net revenues exceed $3,000,000 and net income exceeds 25% of net revenues in the year ended December 31, 2020, an additional $1,000,000 in consideration will be due to the key individuals. If GKMP net revenues exceed $6,000,000 and net income exceeds 25% of net revenues in the year ended December 31, 2020, an additional $500,000 in consideration will be due to the key individuals ($1,500,000 in the aggregate).</cbds.com:NetRevenuesDescription>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f15" decimals="0" contextRef="c11" unitRef="usd">592075.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock id="f16" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Basis of Presentation:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fiscal year end is December 31. The accompanying&#13;condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019, have been prepared in accordance with accounting&#13;principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;) for interim financial information and&amp;#160;accordingly,&#13;they do not include all of the information and footnotes required by GAAP for complete financial statements.&amp;#160;In the opinion&#13;of the Company&amp;#8217;s management all material adjustments (consisting only of normal recurring adjustments) which are considered&#13;necessary for a fair presentation of the interim financial statements have been included. &amp;#160;Operating results for the three&#13;months ended March 31, 2020 are not necessarily indicative of the results of operations expected for the year ending December 31,&#13;2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The interim financial statements should be&#13;read in conjunction with the audited financial statements and related footnotes set forth in our annual report filed on Form 10-K&#13;for the year ended December 31, 2019 as filed with the United States Securities and Exchange Commission on May 14, 2020.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:MinorityInterestOwnershipPercentageByParent id="f17" decimals="INF" contextRef="c12" unitRef="pure">0.49</us-gaap:MinorityInterestOwnershipPercentageByParent>
  <dei:EntityEmergingGrowthCompany id="f18" contextRef="c1">false</dei:EntityEmergingGrowthCompany>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f19" decimals="0" contextRef="c13" unitRef="usd">0.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <dei:EntityShellCompany id="f20" contextRef="c1">false</dei:EntityShellCompany>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f21" decimals="0" contextRef="c14" unitRef="usd">116000.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:ReceivablesPolicyTextBlock id="f22" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Accounts Receivable:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We estimate credit loss reserves for&#13;accounts receivable on an individual receivable basis. A specific allowance reserve is established based on expected future&#13;cash flows and the financial condition of the debtor.&amp;#160;&amp;#160;We charge off customer balances in part or in full when it&#13;is more likely than not that we will not collect that amount of the balance due.&amp;#160;&amp;#160;We consider any balance unpaid&#13;after the contract payment period to be past due.&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
  <cbds.com:AdditionalWorkingCapital id="f23" decimals="0" contextRef="c10" unitRef="usd">500000.0</cbds.com:AdditionalWorkingCapital>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f24" decimals="0" contextRef="c15" unitRef="usd">116000.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:UseOfEstimates id="f25" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Use of Estimates:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of financial statements in&#13;conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated&#13;financial statements and accompanying notes. &lt;font style="color: #212529"&gt;Significant estimates and assumptions by management affect&#13;the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), the provision&#13;for income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, and the value&#13;attributed to stock-based awards.&lt;/font&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
  <cbds.com:WorkingCapitalPayments id="f26" decimals="INF" contextRef="c10" unitRef="pure">0.49</cbds.com:WorkingCapitalPayments>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f27" decimals="0" contextRef="c16" unitRef="usd">22226.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ConsolidationPolicyTextBlock id="f28" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Principles of Consolidation:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The condensed consolidated financial statements&#13;include the accounts of Cannabis Sativa, Inc., and its wholly-owned subsidiaries; Wild Earth Naturals, Inc., Hi-Brands International,&#13;Inc., Eden Holdings LLC, our 50.1% ownership of iBudtender Inc., our 51% ownership of PrestoCorp, and our 51% ownership of GK Manufacturing&#13;Inc., (collectively referred to as the &amp;#8220;Company&amp;#8221;). &amp;#160;All significant inter-company balances have been eliminated&#13;in consolidation. We hold controlling interests in iBudTender, PrestoCorp and GK Manufacturing and exercise control through management&#13;practices and oversight by the Company&amp;#8217;s Board of Directors. GK Manufacturing was established in February 2020.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:Goodwill id="f29" decimals="0" contextRef="c17" unitRef="usd">1837202.0</us-gaap:Goodwill>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="f30" contextRef="c18">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy id="f31" contextRef="c1">&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Fair Value of Financial Instruments:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The carrying amounts of&amp;#160;cash and cash&#13;equivalents and amounts due to related parties approximate fair value given their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <cbds.com:AssetsValueDescription id="f32" contextRef="c10">The assets were valued at $213,725, of which $104,725 relates to the 49% non-controlling interest. GKMP also assumed the payments on a lease for equipment, agreed to provide up to $500,000 of additional working capital to GKMP, and agreed to an earnout provision where additional shares of common stock may become issuable to the key individuals in the event certain performance standards are met</cbds.com:AssetsValueDescription>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f33" decimals="0" contextRef="c17" unitRef="usd">1939912.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:EarningsPerSharePolicyTextBlock id="f34" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Net Loss per Share:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Net loss per share is computed by dividing&#13;net loss available to common shareholders by the weighted average number of common shares outstanding for the period and contains&#13;no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings&#13;of the Company. &amp;#160;Potentially dilutive shares are excluded from the calculation of diluted net loss per share because the effect&#13;is anti-dilutive. At March 31, 2020 and March 31, 2019 the Company had 125,000 and 49,900 outstanding warrants, respectively, that&#13;would be dilutive to future periods net income. Also, at March 31, 2020 and March 31, 2019 the Company had 1,254,012 and 798,835&#13;shares of convertible Series A preferred stock, respectively, that would be dilutive to future periods net income. See Note 6.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="f35" contextRef="c18">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:IncreaseDecreaseInInventories id="f36" decimals="0" contextRef="c1" unitRef="usd">16905.0</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:Goodwill id="f37" decimals="0" contextRef="c19" unitRef="usd">1837202.0</us-gaap:Goodwill>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f38" decimals="0" contextRef="c20" unitRef="usd">1021.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="f39" contextRef="c21">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:MinorityInterestOwnershipPercentageByParent id="f40" decimals="INF" contextRef="c22" unitRef="pure">0.51</us-gaap:MinorityInterestOwnershipPercentageByParent>
  <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock id="f41" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Going Concern:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has an accumulated deficit of $75,471,554&#13;at March 31, 2020, which, among other factors, raises substantial doubt about the Company&amp;#8217;s ability to continue as a going&#13;concern. The ability of the Company to continue as a going concern is dependent on the Company&amp;#8217;s ability to generate profitable&#13;operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from&#13;normal business operations when they are due.&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="f42" decimals="0" contextRef="c1" unitRef="usd">30.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:ConversionOfStockSharesConverted1 id="f43" decimals="INF" contextRef="c1" unitRef="shares">80337.0</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f44" decimals="0" contextRef="c19" unitRef="usd">1160754.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:GoodwillImpairmentLoss id="f45" decimals="0" contextRef="c23" unitRef="usd">3010202.0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f46" decimals="0" contextRef="c24" unitRef="usd">24342.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="f47" contextRef="c21">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f48" decimals="0" contextRef="c25" unitRef="usd">74834032.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="f49" decimals="0" contextRef="c26" unitRef="usd">-2282.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:InventoryPolicyTextBlock id="f50" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Inventories:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventory costs, when applicable, include those&#13;costs directly attributable to the manufacture of the product before sale. Inventory consists of raw materials and finished goods&#13;and is carried at the lower of cost or net realizable value, using the first-in, first-out method of determining cost. &amp;#160;As&#13;of March 31, 2020, the Company had $64,892 in inventory relating to GKMP. Inventory consists of the raw materials and packaging&#13;used to manufacture CBD infused products for our customers. As of December 31, 2019, the Company had no inventory.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f51" decimals="0" contextRef="c27" unitRef="usd">76173444.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ConversionOfStockDescription id="f52" contextRef="c1">In the three months ended March 31, 2020, a related party converted 80,337 preferred shares into 80,337 shares of common stock. No preferred shares were converted in the three months ended March 31, 2019</us-gaap:ConversionOfStockDescription>
  <us-gaap:Depreciation id="f53" decimals="0" contextRef="c1" unitRef="usd">317.0</us-gaap:Depreciation>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f54" decimals="0" contextRef="c28" unitRef="usd">-74855147.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="f55" contextRef="c1">&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Property and Equipment:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment are recorded at cost.&#13;&amp;#160;Depreciation is provided for on the straight-line method over the estimated useful lives of the assets. &amp;#160;The average&#13;lives range from five (5) to ten (10) years. &amp;#160;Leasehold improvements are amortized on the straight-line method over the lesser&#13;of the lease term or the useful life. Maintenance and repairs that neither materially add to the value of the property nor appreciably&#13;prolong its life are charged to expense as incurred. &amp;#160;Betterments or renewals are capitalized when incurred. &amp;#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f56" decimals="0" contextRef="c29" unitRef="usd">-75471554.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:GoodwillImpairmentLoss id="f57" decimals="0" contextRef="c30" unitRef="usd">336667.0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f58" decimals="0" contextRef="c31" unitRef="usd">1107480.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:PropertyPlantAndEquipmentGross id="f59" decimals="0" contextRef="c17" unitRef="usd">196269.0</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f60" decimals="0" contextRef="c32" unitRef="usd">1111882.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AdvertisingCostsPolicyTextBlock id="f61" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Advertising Expense:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Advertising costs are expensed&#13;as incurred and are included in general and administrative expense in the accompanying consolidated statements of operations. Advertising&#13;costs were $87,088 and $33,153 for the three months ended March 31, 2020 and 2019, respectively.&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets id="f62" decimals="0" contextRef="c1" unitRef="usd">53000.0</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f63" decimals="0" contextRef="c33" unitRef="usd">51142.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f64" decimals="0" contextRef="c34" unitRef="usd">50173.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:Depreciation id="f65" decimals="0" contextRef="c26" unitRef="usd">779.0</us-gaap:Depreciation>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock id="f66" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Cash:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 57.75pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash is held at major financial institutions&#13;and insured by the Federal Deposit Insurance Corporation (FDIC) up to federal insurance limits. The Company considers all highly&#13;liquid investments purchased with an original maturity of three months or less when acquired to be cash equivalents.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentGross id="f67" decimals="0" contextRef="c35" unitRef="usd">193769.0</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:IncreaseDecreaseInInventories id="f68" decimals="0" contextRef="c26" unitRef="usd">-5714.0</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f69" decimals="0" contextRef="c36" unitRef="usd">759.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f70" decimals="0" contextRef="c37" unitRef="usd">799.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:InvestmentPolicyTextBlock id="f71" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Investments&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Investments in equity securities&#13;that are less than 20% owned are stated at fair value. The Company recognizes unrealized holding gains and losses in other (Income)&#13;Expenses in the condensed consolidated statement of operations. On disposal of an investment, the difference between the disposal&#13;proceeds and the carrying amount is recognized as income or loss on the condensed consolidated statement of operations.&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
  <us-gaap:IncreaseDecreaseInPrepaidExpense id="f72" decimals="0" contextRef="c1" unitRef="usd">5824.0</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f73" decimals="0" contextRef="c38" unitRef="usd">21318.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:PropertyPlantAndEquipmentGross id="f74" decimals="0" contextRef="c19" unitRef="usd">19914.0</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f75" decimals="0" contextRef="c39" unitRef="usd">21410.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets id="f76" decimals="0" contextRef="c26" unitRef="usd">0.0</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:PropertyPlantAndEquipmentGross id="f77" decimals="0" contextRef="c40" unitRef="usd">2500.0</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f78" decimals="0" contextRef="c41" unitRef="usd">72971563.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f79" decimals="0" contextRef="c42" unitRef="usd">73541728.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock id="f80" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Intangible Assets and Goodwill:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We account for intangible assets and goodwill&#13;in accordance with ASC 350 &lt;i&gt;&amp;#8220;Intangibles-Goodwill and Other&amp;#8221;&lt;/i&gt; (&amp;#8220;ASC 350&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Intangible asset amounts represent&#13;the acquisition date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined&#13;by using the income approach, discounting projected future cash flows based on management&amp;#8217;s expectations of the current and&#13;future operating environment. The rates used to discount projected future cash flows reflected a weighted average cost of capital&#13;based on our industry, capital structure and risk premiums including those reflected in the current market capitalization. Definite-lived&#13;intangible assets are amortized over their useful lives, which have historically ranged from 5 to 10 years. The carrying amounts&#13;of our definite-lived intangible assets are evaluated for recoverability whenever events or changes in circumstances indicate that&#13;the entity may be unable to recover the asset&amp;#8217;s carrying amount. We do not have any indefinite-lived intangible assets recorded&#13;from acquisitions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Goodwill represents the excess&#13;of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill&#13;is not amortized but is tested for impairment annually or more frequently if events or changes in circumstances indicate that the&#13;asset may be impaired. The fair value of the reporting unit is evaluated on qualitative factors to determine if the reported value&#13;may be impaired. If the qualitative factors indicate a likelihood of impairment, we then evaluate carrying value of the reporting&#13;unit based on quantitative factors using the income approach. An impairment charge is recognized for the excess of the carrying&#13;value of goodwill for the reporting unit over its implied fair value.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentGross id="f81" decimals="0" contextRef="c43" unitRef="usd">17414.0</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f82" decimals="0" contextRef="c44" unitRef="usd">-70918761.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:FairValueNetAssetLiability id="f83" decimals="0" contextRef="c22" unitRef="usd">109000.0</us-gaap:FairValueNetAssetLiability>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="f84" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Stock-Based Compensation:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -45pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Stock-based payments to employees&#13;and non-employees are recognized at their fair values.&amp;#160;&amp;#160;Compensation expense is recognized over the period during which&#13;an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting&#13;period). The Company uses the Black-Scholes option pricing model when necessary as the most appropriate fair value method for option&#13;awards. Most awards have been in the form of shares of the Company&amp;#8217;s common and preferred stock issued under the Company&amp;#8217;s&#13;2017 Stock Plan. See Note 6. The Company currently recognizes compensation costs immediately as our awards are 100% vested at the&#13;time of issuance.&amp;#160;&amp;#160;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f85" decimals="0" contextRef="c45" unitRef="usd">-71641520.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="f86" decimals="0" contextRef="c1" unitRef="usd">11867.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentGross id="f87" decimals="0" contextRef="c46" unitRef="usd">2500.0</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:IncomeTaxPolicyTextBlock id="f88" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Income Taxes:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;The Company utilizes the liability&#13;method of accounting for income taxes which requires that deferred tax assets and liabilities be recorded to reflect the future&#13;tax consequences of temporary differences between the book and tax basis of various assets and liabilities.&amp;#160;&amp;#160;Deferred&#13;tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those&#13;temporary differences are expected to be recovered or settled. Additionally, deferred tax assets are evaluated, and a valuation&#13;allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. There&#13;can be no assurance that the Company&amp;#8217;s future operations will produce sufficient earnings so that the deferred tax asset&#13;can be fully utilized. The Company currently maintains a full valuation allowance against net deferred tax assets.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:IncreaseDecreaseInPrepaidExpense id="f89" decimals="0" contextRef="c26" unitRef="usd">7617.0</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f90" decimals="0" contextRef="c47" unitRef="usd">1105495.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="f91" decimals="0" contextRef="c17" unitRef="usd">13791.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <cbds.com:TotalStockIssuedShares id="f92" decimals="INF" contextRef="c48" unitRef="shares">0.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f93" decimals="0" contextRef="c49" unitRef="usd">1092030.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f94" decimals="0" contextRef="c50" unitRef="usd">123454.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AmortizationOfIntangibleAssets id="f95" decimals="0" contextRef="c1" unitRef="usd">51318.0</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount id="f96" decimals="0" contextRef="c17" unitRef="usd">5498.0</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f97" decimals="0" contextRef="c51" unitRef="usd">111020.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="f98" decimals="0" contextRef="c26" unitRef="usd">128.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f99" xsi:nil="true" contextRef="c52" unitRef="usd"/>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f100" xsi:nil="true" contextRef="c53" unitRef="usd"/>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="f101" decimals="0" contextRef="c19" unitRef="usd">13474.0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:LesseeLeasesPolicyTextBlock id="f102" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Leases:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;The Company determines if an&#13;arrangement is a lease, or contains a lease, at the inception of an arrangement. If the Company determines that the arrangement&#13;is a lease, or contains a lease, at lease inception, it then determines whether the lease is an operating lease or finance lease.&#13;Operating and finance leases result in recording a right-of-use (&amp;#8220;ROU&amp;#8221;) asset and lease liability on the consolidated&#13;balance sheets. ROU assets represent the Company&amp;#8217;s right to use an underlying asset for the lease term and lease liabilities&#13;represent the Company&amp;#8217;s obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities&#13;are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating&#13;operating lease ROU assets and operating lease liabilities, the Company uses the non-cancellable lease term plus options to extend&#13;that it is reasonably certain to exercise. Lease expense for operating lease payments is recognized on a straight-line basis over&#13;the lease term. The Company&amp;#8217;s leases generally do not provide an implicit rate. As such, the Company uses its incremental&#13;borrowing rate based on the information available at commencement date in determining the present value of lease payments. The&#13;Company has elected not to recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for&#13;any class of underlying asset. The Company has elected not to separate lease and non-lease components for any class of underlying&#13;asset.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
  <us-gaap:ProceedsFromPreviousAcquisition id="f103" decimals="0" contextRef="c1" unitRef="usd">50000.0</us-gaap:ProceedsFromPreviousAcquisition>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f104" xsi:nil="true" contextRef="c54" unitRef="usd"/>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f105" decimals="0" contextRef="c55" unitRef="usd">50372.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="f106" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Recent Accounting Pronouncements:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Accounting Standards Updates Adopted&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;In January 2017, the&#13;FASB issued ASU 2017-04,&amp;#160;Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The&#13;update simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill&#13;impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit&amp;#8217;s&#13;goodwill with the carrying amount. This update is effective for annual and interim periods beginning after December 15, 2019,&#13;and interim periods within that reporting period. The adoption of the new guidance on January 1, 2020 did not have a material&#13;impact on the Company&amp;#8217;s&amp;#160;consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;In August 2018, the FASB issued&#13;ASU No. 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value&#13;Measurement. The update removes, modifies, and makes additions to the disclosure requirements on fair value measurements. The update&#13;was adopted as of January 1, 2020, and its adoption did not have a material impact on the Company&amp;#8217;s financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Accounting Standards Updates to Become Effective&#13;in Future Periods&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;In December 2019, the FASB&#13;issued ASU No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update contains a number of provisions&#13;intended to simplify the accounting for income taxes. The update is effective for fiscal years beginning after December 15, 2020,&#13;with early adoption permitted. Management is evaluating the impact of this update on the Company&amp;#8217;s financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Other accounting standards&#13;that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material&#13;impact on the financial statements upon adoption.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f107" decimals="0" contextRef="c56" unitRef="usd">3303828.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths id="f108" decimals="0" contextRef="c17" unitRef="usd">196239.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:ProceedsFromPreviousAcquisition id="f109" decimals="0" contextRef="c26" unitRef="usd">0.0</us-gaap:ProceedsFromPreviousAcquisition>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="f110" decimals="0" contextRef="c57" unitRef="usd">3125467.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AmortizationOfIntangibleAssets id="f111" decimals="0" contextRef="c26" unitRef="usd">139739.0</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:FairValueMeasurementPolicyPolicyTextBlock id="f112" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;When required to measure assets&#13;or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding&#13;the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their&#13;entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to&#13;the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant&#13;other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period&#13;are included in earnings&amp;#160;that are attributable to the change in unrealized gains or losses relating to those assets and liabilities&#13;still held at the reporting date. We measure our investment in equity securities at fair value on a recurring basis.&amp;#160;&amp;#160;The&#13;Company&amp;#8217;s equity securities are valued using inputs observable in active markets and are therefore classified as Level 1&#13;within the fair value hierarchy.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
  <us-gaap:ProfitLoss id="f113" decimals="0" contextRef="c1" unitRef="usd">-667327.0</us-gaap:ProfitLoss>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="f114" decimals="INF" contextRef="c58" unitRef="pure">0.0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <cbds.com:AmortizationTableTextBlock id="f115" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization of intangibles for each of the&#13;next five years is:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 84%; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;196,239&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;167,323&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;159,321&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;121,017&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</cbds.com:AmortizationTableTextBlock>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="f116" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Revenue Recognition: &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenues are recognized when control of the&#13;promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects&#13;to receive in exchange for those goods or services. The Company recognizes revenue from the sale of products and services in accordance&#13;with ASC 606,&amp;#8221; Revenue &lt;i&gt;Recognition&lt;/i&gt;&amp;#8221;. The Company applies the following five steps in order to determine the&#13;appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 8%"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 92%"&gt;&lt;font style="font-size: 10pt"&gt;identify the contract with a customer;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;identify the performance obligations in the contract;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;determine the transaction price;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;allocate the transaction price to performance obligations in the contract; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;recognize revenue as the performance obligation is satisfied.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Provision for sales incentives, discounts and&#13;returns and allowances, if applicable, are accounted for as reductions of revenue in the period the related sales are recorded.&#13;The Company had no warranty costs associated with the sales of its products in the periods presented in the accompanying Consolidated&#13;Statements of Operations and no provision for warranty expenses has been included.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;The Company generates revenue&#13;based on a per telehealth visit basis for clients looking to obtain a permit to use marijuana for medical purposes in states that&#13;have legalized medical marijuana. Revenues are recognized when the Company satisfies its performance obligation to stand ready&#13;to provide telehealth services. This occurs at the same time an online client subscribes for the visit and gains access to our&#13;network of health care professionals. The billing and payment processes are automated through our online platform. Revenue is recognized&#13;in an amount that reflects the consideration that is received in exchange for the service.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;With the recent addition of&#13;GKMP, the Company will also be reporting revenue from manufacturing operations in future periods. The Company will recognize revenue&#13;from manufacturing operations when manufacturing and packaging processes are complete, and the products are shipped to the customer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In the quarter ended March 31, 2020, the Company&#13;operated as one reportable segment.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ProfitLoss id="f117" xsi:nil="true" contextRef="c59" unitRef="usd"/>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo id="f118" decimals="0" contextRef="c17" unitRef="usd">167323.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock id="f119" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table breaks out&#13;the issuances by type of transaction and by related and non-related parties under the plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Three months ended March 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Acquistions&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Services&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; width: 24%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Related Parties&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Common&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Common&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Preferred&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Common&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Preferred&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;David Tobias, Officer, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;42,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;42,857&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Brad Herr, Officer, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;131,964&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;63,342&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;131,964&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;63,342&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Robert Tankson, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;84,326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;40,476&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;84,326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;40,476&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Cathy Carroll, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;42,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;42,857&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Trevor Reed, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,881&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;7,142&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,881&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;7,142&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total for related parties&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;320,457&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;196,674&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;320,457&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;196,674&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Related parties - acquistion&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;109,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;652,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;395,401&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;752,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;504,401&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Aggregate Totals&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;109,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;973,380&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;592,075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,073,380&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;701,075&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table breaks out the issuances by type of transaction and by&#13;related and non-related parties under the plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Three months ended March 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Services&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Common&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Preferred&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Unrelated parties issued&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;35,000 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;116,000 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Unrelated Parties Cancelled&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(70,000)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Aggregate Totals&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(35,000)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;116,000 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
  <us-gaap:ProfitLoss id="f120" xsi:nil="true" contextRef="c60" unitRef="usd"/>
  <us-gaap:OfficersCompensation id="f121" decimals="0" contextRef="c61" unitRef="usd">196674.0</us-gaap:OfficersCompensation>
  <cbds.com:IncreaseDecreaseAccruedInterestRelatedParties id="f122" decimals="0" contextRef="c1" unitRef="usd">-12788.0</cbds.com:IncreaseDecreaseAccruedInterestRelatedParties>
  <us-gaap:ProfitLoss id="f123" xsi:nil="true" contextRef="c62" unitRef="usd"/>
  <us-gaap:NotesPayable id="f124" decimals="0" contextRef="c58" unitRef="usd">10142.0</us-gaap:NotesPayable>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree id="f125" decimals="0" contextRef="c17" unitRef="usd">159321.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:ProfitLoss id="f126" decimals="0" contextRef="c26" unitRef="usd">-748658.0</us-gaap:ProfitLoss>
  <cbds.com:BadDebts id="f127" decimals="0" contextRef="c1" unitRef="usd">0.0</cbds.com:BadDebts>
  <us-gaap:ProfitLoss id="f128" xsi:nil="true" contextRef="c63" unitRef="usd"/>
  <cbds.com:TotalStockIssuedShares id="f129" decimals="INF" contextRef="c64" unitRef="shares">320457.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:ProfitLoss id="f130" xsi:nil="true" contextRef="c65" unitRef="usd"/>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour id="f131" decimals="0" contextRef="c17" unitRef="usd">121017.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <cbds.com:IncreaseDecreaseAccruedInterestRelatedParties id="f132" decimals="0" contextRef="c26" unitRef="usd">0.0</cbds.com:IncreaseDecreaseAccruedInterestRelatedParties>
  <us-gaap:ProfitLoss id="f133" xsi:nil="true" contextRef="c66" unitRef="usd"/>
  <us-gaap:OfficersCompensation id="f134" decimals="0" contextRef="c67" unitRef="usd">0.0</us-gaap:OfficersCompensation>
  <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent id="f135" decimals="0" contextRef="c17" unitRef="usd">1084020.0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="f136" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment consisted of the following&#13;at March 31, 2020 and December 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; width: 55%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; width: 22%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;March 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; width: 23%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right; vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;193,769&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right; vertical-align: top"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;17,414&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Leasehold Improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: right; vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;2,500&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: right; vertical-align: top"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;2,500&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; vertical-align: top; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right; vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;196,269&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right; vertical-align: top"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;19,914&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less: &amp;#160;Accumulated Depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; text-align: right; vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(13,791)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; text-align: right; vertical-align: top"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(13,474)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Net Property and Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; text-align: right; vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;182,478&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; text-align: right; vertical-align: top"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;6,440&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ProfitLoss id="f137" decimals="0" contextRef="c68" unitRef="usd">-616407.0</us-gaap:ProfitLoss>
  <cbds.com:TotalStockIssuedShares id="f138" decimals="INF" contextRef="c69" unitRef="shares">14881.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:ProfitLoss id="f139" decimals="0" contextRef="c70" unitRef="usd">-722759.0</us-gaap:ProfitLoss>
  <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent id="f140" decimals="0" contextRef="c19" unitRef="usd">1018520.0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
  <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock id="f141" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all intangibles to be&#13;definite-lived assets with lives of 5 to 10 years. Intangibles consisted of the following at March 31, 2020 and December 31, 2019:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 4in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; width: 59%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; width: 19%"&gt;&lt;font style="font-size: 10pt"&gt;March 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; width: 22%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;CBDS.com website (Cannabis Sativa)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;13,999&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;13,999&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Intellectual Property Rights (PrestoCorp)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;240,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;240,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Patents and Trademarks (KPAL)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;1,281,411&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;1,281,411&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total Intangibles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;1,535,410&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;1,535,410&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less: &amp;#160;Accumulated Amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(891,510)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(840,192)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Net Intangible Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;643,900&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;695,218&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
  <cbds.com:TotalStockIssuedShares id="f142" decimals="INF" contextRef="c71" unitRef="shares">89286.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:ProfitLoss id="f143" decimals="0" contextRef="c72" unitRef="usd">4402.0</us-gaap:ProfitLoss>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="f144" decimals="INF" contextRef="c21" unitRef="pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <cbds.com:BadDebts id="f145" decimals="0" contextRef="c26" unitRef="usd">-1461.0</cbds.com:BadDebts>
  <us-gaap:ProfitLoss id="f146" decimals="0" contextRef="c73" unitRef="usd">-13465.0</us-gaap:ProfitLoss>
  <cbds.com:TotalStockIssuedShares id="f147" decimals="INF" contextRef="c74" unitRef="shares">84326.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="f148" decimals="INF" contextRef="c18" unitRef="pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:ProfitLoss id="f149" decimals="0" contextRef="c75" unitRef="usd">-969.0</us-gaap:ProfitLoss>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="f150" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Future minimum lease payments over the remaining term are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt; width: 78%"&gt;&lt;font style="font-size: 10pt"&gt;Nine months ended December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right; width: 22%"&gt;&lt;font style="font-size: 10pt"&gt;$&amp;#9;6,143&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Twelve months ended December 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;8,190&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Twelve months ended December 31, 2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;8,190&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Six months ended June 30, 2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;4,095&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: black 1pt solid; padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;26,618&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Less imputed interest&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(5,498)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Net lease liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;21,120&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Current portion&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(6,498)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Long term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&amp;#9;14,622&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:OtherGeneralAndAdministrativeExpense id="f151" decimals="0" contextRef="c76" unitRef="usd">45000.0</us-gaap:OtherGeneralAndAdministrativeExpense>
  <cbds.com:TotalStockIssuedShares id="f152" decimals="INF" contextRef="c77" unitRef="shares">131964.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:ProfitLoss id="f153" decimals="0" contextRef="c78" unitRef="usd">-12434.0</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="f154" xsi:nil="true" contextRef="c79" unitRef="usd"/>
  <cbds.com:TotalStockIssuedShares id="f155" decimals="INF" contextRef="c80" unitRef="shares">752923.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:ProfitLoss id="f156" decimals="0" contextRef="c81" unitRef="usd">-54353.0</us-gaap:ProfitLoss>
  <us-gaap:NotesPayable id="f157" decimals="0" contextRef="c82" unitRef="usd">10142.0</us-gaap:NotesPayable>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f158" xsi:nil="true" contextRef="c68" unitRef="usd"/>
  <cbds.com:TotalStockIssuedShares id="f159" decimals="INF" contextRef="c83" unitRef="shares">1073380.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:InterestExpense id="f160" decimals="0" contextRef="c1" unitRef="usd">13552.0</us-gaap:InterestExpense>
  <cbds.com:CommonStockIssuedToCompensateEmployeesAndConsultants id="f161" decimals="INF" contextRef="c84" unitRef="shares">3000000.0</cbds.com:CommonStockIssuedToCompensateEmployeesAndConsultants>
  <cbds.com:TotalStockIssuedShares id="f162" decimals="INF" contextRef="c85" unitRef="shares">89286.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:OtherGeneralAndAdministrativeExpense id="f163" decimals="0" contextRef="c86" unitRef="usd">17000.0</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:InterestExpense id="f164" decimals="0" contextRef="c87" unitRef="usd">10843.0</us-gaap:InterestExpense>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f165" xsi:nil="true" contextRef="c63" unitRef="shares"/>
  <cbds.com:TotalStockIssuedShares id="f166" decimals="INF" contextRef="c88" unitRef="shares">0.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:InterestExpense id="f167" decimals="0" contextRef="c89" unitRef="usd">13552.0</us-gaap:InterestExpense>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f168" decimals="INF" contextRef="c59" unitRef="shares">89286.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedShares id="f169" decimals="INF" contextRef="c90" unitRef="shares">0.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:InterestExpense id="f170" decimals="0" contextRef="c26" unitRef="usd">10843.0</us-gaap:InterestExpense>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="f171" decimals="0" contextRef="c91" unitRef="usd">196674.0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PreferredStockVotingRights id="f172" contextRef="c92">1 vote per share</us-gaap:PreferredStockVotingRights>
  <cbds.com:TotalStockIssuedShares id="f173" decimals="INF" contextRef="c93" unitRef="shares">0.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f174" decimals="INF" contextRef="c59" unitRef="shares">223214.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f175" decimals="INF" contextRef="c62" unitRef="shares">35000.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedShares id="f176" decimals="INF" contextRef="c94" unitRef="shares">0.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f177" decimals="INF" contextRef="c62" unitRef="shares">127061.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f178" decimals="INF" contextRef="c60" unitRef="shares">973380.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f179" decimals="INF" contextRef="c48" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedShares id="f180" decimals="INF" contextRef="c95" unitRef="shares">89286.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="f181" decimals="0" contextRef="c96" unitRef="usd">340198.0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f182" decimals="INF" contextRef="c77" unitRef="shares">131964.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedShares id="f183" decimals="INF" contextRef="c97" unitRef="shares">0.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f184" decimals="INF" contextRef="c74" unitRef="shares">84326.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f185" decimals="INF" contextRef="c60" unitRef="shares">963238.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f186" decimals="INF" contextRef="c71" unitRef="shares">89286.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedShares id="f187" decimals="INF" contextRef="c98" unitRef="shares">89286.0</cbds.com:TotalStockIssuedShares>
  <us-gaap:InvestmentTextBlock id="f188" contextRef="c1">&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;5. Investments.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In 2018, the Company purchased 10,000,000 shares&#13;of common stock of Medical Cannabis Payment Solutions (ticker: &amp;#160;REFG) in exchange for 1,000,000 units of Weed coins (valued&#13;at $200,000). At March 31, 2020, the fair value of the investment in REFG was adjusted to $67,000 based on the closing price of&#13;the stock on that date, which resulted in an unrealized gain on investment of $19,000 during the three month period ended March&#13;31, 2020. At December 31, 2019, the fair value of the investment in REFG was adjusted to $48,000 based on the closing price of&#13;the stock on that date, which resulted in an unrealized loss on investment of $152,000 during the year ended December 31, 2019.&lt;/p&gt;</us-gaap:InvestmentTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f189" decimals="INF" contextRef="c69" unitRef="shares">14881.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedValue id="f190" decimals="0" contextRef="c" unitRef="usd">42857.0</cbds.com:TotalStockIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f191" decimals="INF" contextRef="c63" unitRef="shares">39391.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f192" decimals="INF" contextRef="c64" unitRef="shares">320457.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f193" decimals="INF" contextRef="c80" unitRef="shares">652923.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedValue id="f194" decimals="0" contextRef="c8" unitRef="usd">196674.0</cbds.com:TotalStockIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f195" decimals="INF" contextRef="c99" unitRef="shares">223214.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f196" decimals="INF" contextRef="c83" unitRef="shares">973380.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f197" decimals="INF" contextRef="c100" unitRef="shares">521411.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f198" decimals="INF" contextRef="c85" unitRef="shares">89286.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedValue id="f199" decimals="0" contextRef="c6" unitRef="usd">7142.0</cbds.com:TotalStockIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f200" decimals="INF" contextRef="c88" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f201" decimals="INF" contextRef="c101" unitRef="shares">39391.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <cbds.com:TotalStockIssuedValue id="f202" decimals="0" contextRef="c4" unitRef="usd">42857.0</cbds.com:TotalStockIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f203" decimals="INF" contextRef="c90" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="f204" decimals="INF" contextRef="c102" unitRef="shares">85681.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f205" decimals="INF" contextRef="c93" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedValue id="f206" decimals="0" contextRef="c3" unitRef="usd">40476.0</cbds.com:TotalStockIssuedValue>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="f207" decimals="INF" contextRef="c103" unitRef="pure">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f208" decimals="INF" contextRef="c94" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedValue id="f209" decimals="0" contextRef="c2" unitRef="usd">63342.0</cbds.com:TotalStockIssuedValue>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f210" decimals="INF" contextRef="c95" unitRef="shares">89286.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f211" decimals="0" contextRef="c1" unitRef="usd">592075.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f212" decimals="INF" contextRef="c97" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedValue id="f213" decimals="0" contextRef="c9" unitRef="usd">504401.0</cbds.com:TotalStockIssuedValue>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="f214" decimals="INF" contextRef="c104" unitRef="pure">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f215" decimals="INF" contextRef="c98" unitRef="shares">89286.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <cbds.com:TotalStockIssuedValue id="f216" decimals="0" contextRef="c11" unitRef="usd">701075.0</cbds.com:TotalStockIssuedValue>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="f217" decimals="INF" contextRef="c105" unitRef="pure">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f218" decimals="INF" contextRef="c106" unitRef="shares">-70000.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f219" decimals="0" contextRef="c59" unitRef="usd">89.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f220" decimals="INF" contextRef="c107" unitRef="shares">35000.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:OperatingLeaseLiability id="f221" decimals="0" contextRef="c17" unitRef="usd">21120.0</us-gaap:OperatingLeaseLiability>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f222" decimals="0" contextRef="c60" unitRef="usd">973.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f223" decimals="INF" contextRef="c108" unitRef="shares">-35000.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f224" decimals="0" contextRef="c62" unitRef="usd">35.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f225" decimals="INF" contextRef="c109" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="f226" decimals="0" contextRef="c17" unitRef="usd">26618.0</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f227" decimals="INF" contextRef="c110" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f228" decimals="0" contextRef="c26" unitRef="usd">116000.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="f229" decimals="0" contextRef="c17" unitRef="usd">4095.0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f230" xsi:nil="true" contextRef="c63" unitRef="usd"/>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="f231" decimals="INF" contextRef="c111" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f232" decimals="0" contextRef="c65" unitRef="usd">591013.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:OperatingLeaseLiability id="f233" decimals="0" contextRef="c112" unitRef="usd">23286.0</us-gaap:OperatingLeaseLiability>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f234" decimals="0" contextRef="c66" unitRef="usd">115965.0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="f235" decimals="INF" contextRef="c17" unitRef="shares">125000.0</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f236" xsi:nil="true" contextRef="c68" unitRef="usd"/>
  <us-gaap:Deposits id="f237" decimals="0" contextRef="c112" unitRef="usd">1250.0</us-gaap:Deposits>
  <us-gaap:DebtInstrumentPeriodicPayment id="f238" decimals="0" contextRef="c113" unitRef="usd">600.0</us-gaap:DebtInstrumentPeriodicPayment>
  <us-gaap:LesseeOperatingLeaseDiscountRate id="f239" decimals="INF" contextRef="c112" unitRef="pure">0.1</us-gaap:LesseeOperatingLeaseDiscountRate>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f240" xsi:nil="true" contextRef="c70" unitRef="usd"/>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f241" xsi:nil="true" contextRef="c72" unitRef="usd"/>
  <us-gaap:LeaseAndRentalExpense id="f242" decimals="0" contextRef="c23" unitRef="usd">7322.0</us-gaap:LeaseAndRentalExpense>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f243" xsi:nil="true" contextRef="c73" unitRef="usd"/>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="f244" decimals="INF" contextRef="c19" unitRef="shares">174900.0</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="f245" decimals="0" contextRef="c17" unitRef="usd">8190.0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f246" xsi:nil="true" contextRef="c75" unitRef="usd"/>
  <us-gaap:LeaseAndRentalExpense id="f247" decimals="0" contextRef="c10" unitRef="usd">683.0</us-gaap:LeaseAndRentalExpense>
  <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 id="f248" contextRef="c112">P39M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f249" xsi:nil="true" contextRef="c78" unitRef="usd"/>
  <us-gaap:LeaseAndRentalExpense id="f250" decimals="0" contextRef="c114" unitRef="usd">8044.0</us-gaap:LeaseAndRentalExpense>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f251" xsi:nil="true" contextRef="c79" unitRef="usd"/>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="f252" decimals="0" contextRef="c17" unitRef="usd">8190.0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:DebtInstrumentPeriodicPayment id="f253" decimals="0" contextRef="c115" unitRef="usd">1500.0</us-gaap:DebtInstrumentPeriodicPayment>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="f254" xsi:nil="true" contextRef="c81" unitRef="usd"/>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="f255" decimals="0" contextRef="c17" unitRef="usd">6143.0</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:DebtInstrumentPeriodicPayment id="f256" decimals="0" contextRef="c116" unitRef="usd">2800.0</us-gaap:DebtInstrumentPeriodicPayment>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f257" xsi:nil="true" contextRef="c72" unitRef="usd"/>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f258" xsi:nil="true" contextRef="c75" unitRef="usd"/>
  <us-gaap:OperatingExpenses id="f259" decimals="0" contextRef="c1" unitRef="usd">978580.0</us-gaap:OperatingExpenses>
  <us-gaap:OperatingLeaseLiabilityNoncurrent id="f260" decimals="0" contextRef="c17" unitRef="usd">14622.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f261" decimals="0" contextRef="c81" unitRef="usd">104725.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f262" decimals="0" contextRef="c" unitRef="usd">0.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:AdditionalPaidInCapital id="f263" decimals="0" contextRef="c17" unitRef="usd">76173444.0</us-gaap:AdditionalPaidInCapital>
  <us-gaap:OperatingIncomeLoss id="f264" decimals="0" contextRef="c26" unitRef="usd">-737815.0</us-gaap:OperatingIncomeLoss>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="f265" decimals="0" contextRef="c19" unitRef="usd">-74855147.0</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f266" decimals="0" contextRef="c2" unitRef="usd">0.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:GeneralAndAdministrativeExpense id="f267" decimals="0" contextRef="c1" unitRef="usd">375862.0</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:DebtInstrumentPeriodicPayment id="f268" decimals="0" contextRef="c117" unitRef="usd">2444.0</us-gaap:DebtInstrumentPeriodicPayment>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f269" decimals="0" contextRef="c3" unitRef="usd">0.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <dei:EntityFileNumber id="f270" contextRef="c1">000-53571</dei:EntityFileNumber>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f271" decimals="0" contextRef="c4" unitRef="usd">0.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:CommonStockValue id="f272" decimals="0" contextRef="c17" unitRef="usd">24342.0</us-gaap:CommonStockValue>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="f273" decimals="INF" contextRef="c1" unitRef="shares">23510224.0</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f274" decimals="0" contextRef="c6" unitRef="usd">0.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <dei:EntityIncorporationStateCountryCode id="f275" contextRef="c1">NV</dei:EntityIncorporationStateCountryCode>
  <us-gaap:AdditionalPaidInCapital id="f276" decimals="0" contextRef="c19" unitRef="usd">74834032.0</us-gaap:AdditionalPaidInCapital>
  <us-gaap:OperatingExpenses id="f277" decimals="0" contextRef="c26" unitRef="usd">792488.0</us-gaap:OperatingExpenses>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f278" decimals="0" contextRef="c8" unitRef="usd">0.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f279" decimals="0" contextRef="c9" unitRef="usd">109000.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:PreferredStockValue id="f280" decimals="0" contextRef="c17" unitRef="usd">1253.0</us-gaap:PreferredStockValue>
  <us-gaap:AdvertisingExpense id="f281" decimals="0" contextRef="c1" unitRef="usd">87088.0</us-gaap:AdvertisingExpense>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f282" decimals="0" contextRef="c11" unitRef="usd">109000.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:GeneralAndAdministrativeExpense id="f283" decimals="0" contextRef="c26" unitRef="usd">332095.0</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f284" decimals="0" contextRef="c118" unitRef="usd">36000.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <dei:EntityAddressStateOrProvince id="f285" contextRef="c1">NV</dei:EntityAddressStateOrProvince>
  <us-gaap:CommonStockValue id="f286" decimals="0" contextRef="c19" unitRef="usd">22226.0</us-gaap:CommonStockValue>
  <us-gaap:SharesOutstanding id="f287" decimals="INF" contextRef="c20" unitRef="shares">1021849.0</us-gaap:SharesOutstanding>
  <dei:EntityAddressAddressLine1 id="f288" contextRef="c1">450 Hillside Dr. #A224</dei:EntityAddressAddressLine1>
  <us-gaap:SalariesAndWages id="f289" decimals="0" contextRef="c1" unitRef="usd">184909.0</us-gaap:SalariesAndWages>
  <us-gaap:Liabilities id="f290" decimals="0" contextRef="c17" unitRef="usd">1290465.0</us-gaap:Liabilities>
  <us-gaap:SharesOutstanding id="f291" decimals="INF" contextRef="c24" unitRef="shares">24341154.0</us-gaap:SharesOutstanding>
  <dei:EntityAddressCityOrTown id="f292" contextRef="c1">Mesquite</dei:EntityAddressCityOrTown>
  <us-gaap:AdvertisingExpense id="f293" decimals="0" contextRef="c26" unitRef="usd">33153.0</us-gaap:AdvertisingExpense>
  <us-gaap:PreferredStockValue id="f294" decimals="0" contextRef="c19" unitRef="usd">1021.0</us-gaap:PreferredStockValue>
  <us-gaap:SharesOutstanding id="f295" decimals="INF" contextRef="c16" unitRef="shares">22224199.0</us-gaap:SharesOutstanding>
  <us-gaap:OperatingLeaseLiabilityCurrent id="f296" decimals="0" contextRef="c17" unitRef="usd">6498.0</us-gaap:OperatingLeaseLiabilityCurrent>
  <us-gaap:SalariesAndWages id="f297" decimals="0" contextRef="c119" unitRef="usd">50000.0</us-gaap:SalariesAndWages>
  <us-gaap:LiabilitiesNoncurrent id="f298" decimals="0" contextRef="c17" unitRef="usd">14622.0</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:SharesOutstanding id="f299" decimals="INF" contextRef="c5" unitRef="shares">1254012.0</us-gaap:SharesOutstanding>
  <us-gaap:SalariesAndWages id="f300" decimals="0" contextRef="c118" unitRef="usd">65000.0</us-gaap:SalariesAndWages>
  <us-gaap:SharesOutstanding id="f301" decimals="INF" contextRef="c36" unitRef="shares">759444.0</us-gaap:SharesOutstanding>
  <dei:EntityAddressPostalZipCode id="f302" contextRef="c1">89024</dei:EntityAddressPostalZipCode>
  <us-gaap:Liabilities id="f303" decimals="0" contextRef="c19" unitRef="usd">1820763.0</us-gaap:Liabilities>
  <us-gaap:SharesOutstanding id="f304" decimals="INF" contextRef="c37" unitRef="shares">798835.0</us-gaap:SharesOutstanding>
  <us-gaap:SalariesAndWages id="f305" decimals="0" contextRef="c26" unitRef="usd">32634.0</us-gaap:SalariesAndWages>
  <us-gaap:ProfessionalFees id="f306" decimals="0" contextRef="c1" unitRef="usd">279086.0</us-gaap:ProfessionalFees>
  <us-gaap:SharesOutstanding id="f307" decimals="INF" contextRef="c38" unitRef="shares">21316201.0</us-gaap:SharesOutstanding>
  <dei:CityAreaCode id="f308" contextRef="c1">702</dei:CityAreaCode>
  <us-gaap:LiabilitiesNoncurrent id="f309" decimals="0" contextRef="c19" unitRef="usd">640685.0</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:SharesOutstanding id="f310" decimals="INF" contextRef="c39" unitRef="shares">21408262.0</us-gaap:SharesOutstanding>
  <cbds.com:AccruedInterestRelatedParties id="f311" decimals="0" contextRef="c17" unitRef="usd">100767.0</cbds.com:AccruedInterestRelatedParties>
  <dei:LocalPhoneNumber id="f312" contextRef="c1">762-3123</dei:LocalPhoneNumber>
  <us-gaap:LiabilitiesCurrent id="f313" decimals="0" contextRef="c17" unitRef="usd">1275843.0</us-gaap:LiabilitiesCurrent>
  <cbds.com:CancellationOfPerformanceBasedSharesShares id="f314" decimals="INF" contextRef="c62" unitRef="shares">-70000.0</cbds.com:CancellationOfPerformanceBasedSharesShares>
  <us-gaap:OperatingLeaseLiabilityNoncurrent id="f315" decimals="0" contextRef="c19" unitRef="usd">0.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
  <us-gaap:GrossProfit id="f316" decimals="0" contextRef="c1" unitRef="usd">305805.0</us-gaap:GrossProfit>
  <dei:EntityInteractiveDataCurrent id="f317" contextRef="c1">Yes</dei:EntityInteractiveDataCurrent>
  <us-gaap:ProfessionalFees id="f318" decimals="0" contextRef="c26" unitRef="usd">254088.0</us-gaap:ProfessionalFees>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="f319" decimals="INF" contextRef="c59" unitRef="shares">223214.0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:Cash id="f320" decimals="0" contextRef="c17" unitRef="usd">345131.0</us-gaap:Cash>
  <cbds.com:CancellationAndRetirementOfSharesValue id="f321" decimals="0" contextRef="c66" unitRef="usd">70.0</cbds.com:CancellationAndRetirementOfSharesValue>
  <us-gaap:CostOfRevenue id="f322" decimals="0" contextRef="c1" unitRef="usd">187335.0</us-gaap:CostOfRevenue>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="f323" decimals="INF" contextRef="c63" unitRef="shares">39391.0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="f324" decimals="INF" contextRef="c120" unitRef="shares">1254012.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:LiabilitiesCurrent id="f325" decimals="0" contextRef="c19" unitRef="usd">1180078.0</us-gaap:LiabilitiesCurrent>
  <us-gaap:DueToRelatedPartiesCurrent id="f326" decimals="0" contextRef="c17" unitRef="usd">1084020.0</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:Cash id="f327" decimals="0" contextRef="c19" unitRef="usd">336107.0</us-gaap:Cash>
  <us-gaap:GrossProfit id="f328" decimals="0" contextRef="c26" unitRef="usd">54673.0</us-gaap:GrossProfit>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="f329" decimals="INF" contextRef="c62" unitRef="shares">127061.0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:EarningsPerShareBasicAndDiluted id="f330" decimals="INF" contextRef="c1" unitRef="usd1">-0.03</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingLeaseLiabilityCurrent id="f331" decimals="0" contextRef="c19" unitRef="usd">0.0</us-gaap:OperatingLeaseLiabilityCurrent>
  <us-gaap:Revenues id="f332" decimals="0" contextRef="c1" unitRef="usd">493140.0</us-gaap:Revenues>
  <cbds.com:CancellationOfPerformanceBasedSharesShares id="f333" xsi:nil="true" contextRef="c63" unitRef="shares"/>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="f334" decimals="INF" contextRef="c60" unitRef="shares">963238.0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:CostOfRevenue id="f335" decimals="0" contextRef="c26" unitRef="usd">45609.0</us-gaap:CostOfRevenue>
  <cbds.com:ConversionOfPreferredToCommonShares id="f336" decimals="INF" contextRef="c60" unitRef="shares">80337.0</cbds.com:ConversionOfPreferredToCommonShares>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="f337" decimals="INF" contextRef="c26" unitRef="shares">21392324.0</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:NetIncomeLoss id="f338" decimals="0" contextRef="c1" unitRef="usd">-616407.0</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f339" xsi:nil="true" contextRef="c59" unitRef="shares"/>
  <us-gaap:DueToRelatedPartiesCurrent id="f340" decimals="0" contextRef="c19" unitRef="usd">1018520.0</us-gaap:DueToRelatedPartiesCurrent>
  <cbds.com:WarrantsExercisePrice id="f341" decimals="INF" contextRef="c121" unitRef="usd1">0.8</cbds.com:WarrantsExercisePrice>
  <us-gaap:Revenues id="f342" decimals="0" contextRef="c26" unitRef="usd">100282.0</us-gaap:Revenues>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f343" decimals="INF" contextRef="c48" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:EarningsPerShareBasicAndDiluted id="f344" decimals="INF" contextRef="c26" unitRef="usd1">-0.03</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:IncomeLossAttributableToNoncontrollingInterest id="f345" decimals="0" contextRef="c1" unitRef="usd">-50920.0</us-gaap:IncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f346" decimals="INF" contextRef="c77" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="f347" decimals="INF" contextRef="c122" unitRef="shares">798885.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:NetIncomeLoss id="f348" decimals="0" contextRef="c26" unitRef="usd">-722759.0</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f349" decimals="INF" contextRef="c74" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:Assets id="f350" decimals="0" contextRef="c17" unitRef="usd">3230377.0</us-gaap:Assets>
  <us-gaap:IncomeTaxExpenseBenefit id="f351" decimals="0" contextRef="c1" unitRef="usd">0.0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f352" decimals="INF" contextRef="c60" unitRef="shares">100000.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <cbds.com:ConversionOfPreferredToCommonShares id="f353" decimals="INF" contextRef="c59" unitRef="shares">-80337.0</cbds.com:ConversionOfPreferredToCommonShares>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="f354" decimals="INF" contextRef="c123" unitRef="shares">125000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:OperatingLeaseRightOfUseAsset id="f355" decimals="0" contextRef="c17" unitRef="usd">21120.0</us-gaap:OperatingLeaseRightOfUseAsset>
  <us-gaap:IncomeLossAttributableToNoncontrollingInterest id="f356" decimals="0" contextRef="c26" unitRef="usd">-25899.0</us-gaap:IncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f357" decimals="INF" contextRef="c71" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest id="f358" decimals="0" contextRef="c1" unitRef="usd">-667327.0</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
  <cbds.com:WarrantsExercisePrice id="f359" decimals="INF" contextRef="c124" unitRef="usd1">2.0</cbds.com:WarrantsExercisePrice>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="f360" decimals="0" contextRef="c17" unitRef="usd">84558.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f361" decimals="INF" contextRef="c69" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <cbds.com:AccruedInterestRelatedParties id="f362" decimals="0" contextRef="c19" unitRef="usd">87979.0</cbds.com:AccruedInterestRelatedParties>
  <us-gaap:IncomeTaxExpenseBenefit id="f363" decimals="0" contextRef="c26" unitRef="usd">0.0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f364" decimals="INF" contextRef="c64" unitRef="shares">0.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="f365" decimals="INF" contextRef="c125" unitRef="shares">49900.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <cbds.com:LossAttributableToNoncontrollingInterestGkManufacturing id="f366" decimals="0" contextRef="c1" unitRef="usd">54353.0</cbds.com:LossAttributableToNoncontrollingInterestGkManufacturing>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f367" decimals="INF" contextRef="c80" unitRef="shares">100000.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:GoodwillAndIntangibleAssetImpairment id="f368" decimals="0" contextRef="c1" unitRef="usd">1039926.0</us-gaap:GoodwillAndIntangibleAssetImpairment>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="f369" decimals="0" contextRef="c19" unitRef="usd">73579.0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f370" decimals="INF" contextRef="c83" unitRef="shares">100000.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest id="f371" decimals="0" contextRef="c26" unitRef="usd">-748658.0</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="f372" decimals="INF" contextRef="c118" unitRef="shares">50000.0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:OperatingLeaseRightOfUseAsset id="f373" decimals="0" contextRef="c112" unitRef="usd">23286.0</us-gaap:OperatingLeaseRightOfUseAsset>
  <dei:EntityCentralIndexKey id="f374" contextRef="c1">0001360442</dei:EntityCentralIndexKey>
  <cbds.com:CumulativeImpairmentOfGoodwill id="f375" decimals="0" contextRef="c126" unitRef="usd">1173000.0</cbds.com:CumulativeImpairmentOfGoodwill>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="f376" decimals="0" contextRef="c1" unitRef="usd">-94609.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:OtherAssetsNoncurrent id="f377" decimals="0" contextRef="c17" unitRef="usd">2805950.0</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:UnrealizedGainLossOnInvestments id="f378" decimals="0" contextRef="c1" unitRef="usd">19000.0</us-gaap:UnrealizedGainLossOnInvestments>
  <dei:EntityCommonStockSharesOutstanding id="f379" decimals="INF" contextRef="c127" unitRef="shares">24341154.0</dei:EntityCommonStockSharesOutstanding>
  <cbds.com:CancellationAndRetirementOfSharesValue id="f380" xsi:nil="true" contextRef="c70" unitRef="usd"/>
  <us-gaap:UnrealizedGainLossOnInvestments id="f381" decimals="0" contextRef="c128" unitRef="usd">152000.0</us-gaap:UnrealizedGainLossOnInvestments>
  <cbds.com:CumulativeImpairmentOfGoodwill id="f382" decimals="0" contextRef="c23" unitRef="usd">1173000.0</cbds.com:CumulativeImpairmentOfGoodwill>
  <us-gaap:Assets id="f383" decimals="0" contextRef="c19" unitRef="usd">2981517.0</us-gaap:Assets>
  <us-gaap:DepreciationAndAmortization id="f384" decimals="0" contextRef="c1" unitRef="usd">51635.0</us-gaap:DepreciationAndAmortization>
  <dei:CurrentFiscalYearEndDate id="f385" contextRef="c1">--12-31</dei:CurrentFiscalYearEndDate>
  <cbds.com:CumulativeImpairmentOfGoodwill id="f386" decimals="0" contextRef="c129" unitRef="usd">336667.0</cbds.com:CumulativeImpairmentOfGoodwill>
  <cbds.com:LossAttributableToNoncontrollingInterestIbudtender id="f387" decimals="0" contextRef="c1" unitRef="usd">969.0</cbds.com:LossAttributableToNoncontrollingInterestIbudtender>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="f388" decimals="0" contextRef="c1" unitRef="usd">10979.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:OtherAssetsNoncurrent id="f389" decimals="0" contextRef="c19" unitRef="usd">2586860.0</us-gaap:OtherAssetsNoncurrent>
  <cbds.com:LossAttributableToNoncontrollingInterestGkManufacturing id="f390" decimals="0" contextRef="c26" unitRef="usd">0.0</cbds.com:LossAttributableToNoncontrollingInterestGkManufacturing>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="f391" decimals="0" contextRef="c26" unitRef="usd">-106895.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <cbds.com:CumulativeImpairmentOfGoodwill id="f392" decimals="0" contextRef="c30" unitRef="usd">336667.0</cbds.com:CumulativeImpairmentOfGoodwill>
  <cbds.com:GainLossAttributableToNoncontrollingInterestPrestocorp id="f393" decimals="0" contextRef="c1" unitRef="usd">-4402.0</cbds.com:GainLossAttributableToNoncontrollingInterestPrestocorp>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="f394" decimals="0" contextRef="c1" unitRef="usd">592075.0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <dei:EntityCurrentReportingStatus id="f395" contextRef="c1">Yes</dei:EntityCurrentReportingStatus>
  <us-gaap:OperatingLeaseRightOfUseAsset id="f396" decimals="0" contextRef="c19" unitRef="usd">0.0</us-gaap:OperatingLeaseRightOfUseAsset>
  <cbds.com:LossAttributableToNoncontrollingInterestIbudtender id="f397" decimals="0" contextRef="c26" unitRef="usd">12434.0</cbds.com:LossAttributableToNoncontrollingInterestIbudtender>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="f398" decimals="0" contextRef="c17" unitRef="usd">1535410.0</us-gaap:FiniteLivedIntangibleAssetsGross>
  <cbds.com:CancellationAndRetirementOfSharesValue id="f399" xsi:nil="true" contextRef="c26" unitRef="usd"/>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="f400" decimals="0" contextRef="c26" unitRef="usd">31608.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="f401" decimals="0" contextRef="c130" unitRef="usd">13999.0</us-gaap:FiniteLivedIntangibleAssetsGross>
  <dei:AmendmentFlag id="f402" contextRef="c1">false</dei:AmendmentFlag>
  <us-gaap:DepositsAssetsNoncurrent id="f403" decimals="0" contextRef="c17" unitRef="usd">54250.0</us-gaap:DepositsAssetsNoncurrent>
  <cbds.com:GainLossAttributableToNoncontrollingInterestPrestocorp id="f404" decimals="0" contextRef="c26" unitRef="usd">13465.0</cbds.com:GainLossAttributableToNoncontrollingInterestPrestocorp>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="f405" decimals="0" contextRef="c19" unitRef="usd">1535410.0</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="f406" decimals="0" contextRef="c17" unitRef="usd">643900.0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="f407" decimals="0" contextRef="c26" unitRef="usd">467797.0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <cbds.com:CancellationAndRetirementOfSharesValue id="f408" xsi:nil="true" contextRef="c63" unitRef="usd"/>
  <dei:DocumentFiscalYearFocus id="f409" contextRef="c1">2020</dei:DocumentFiscalYearFocus>
  <us-gaap:DepositsAssetsNoncurrent id="f410" decimals="0" contextRef="c19" unitRef="usd">0.0</us-gaap:DepositsAssetsNoncurrent>
  <cbds.com:CancellationAndRetirementOfSharesValue id="f411" decimals="0" contextRef="c62" unitRef="usd">-70.0</cbds.com:CancellationAndRetirementOfSharesValue>
  <us-gaap:DepreciationAndAmortization id="f412" decimals="0" contextRef="c26" unitRef="usd">140518.0</us-gaap:DepreciationAndAmortization>
  <dei:DocumentFiscalPeriodFocus id="f413" contextRef="c1">Q1</dei:DocumentFiscalPeriodFocus>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="f414" decimals="0" contextRef="c131" unitRef="usd">240000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
  <cbds.com:CancellationAndRetirementOfSharesValue id="f415" xsi:nil="true" contextRef="c73" unitRef="usd"/>
  <dei:DocumentType id="f416" contextRef="c1">10-Q</dei:DocumentType>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="f417" decimals="0" contextRef="c132" unitRef="usd">1281411.0</us-gaap:FiniteLivedIntangibleAssetsGross>
  <cbds.com:CancellationAndRetirementOfSharesValue id="f418" xsi:nil="true" contextRef="c78" unitRef="usd"/>
  <us-gaap:UnrealizedGainLossOnInvestments id="f419" decimals="0" contextRef="c26" unitRef="usd">0.0</us-gaap:UnrealizedGainLossOnInvestments>
  <us-gaap:PropertyPlantAndEquipmentNet id="f420" decimals="0" contextRef="c17" unitRef="usd">182478.0</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="f421" decimals="0" contextRef="c133" unitRef="usd">13999.0</us-gaap:FiniteLivedIntangibleAssetsGross>
  <cbds.com:CancellationAndRetirementOfSharesValue id="f422" xsi:nil="true" contextRef="c79" unitRef="usd"/>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="f423" decimals="0" contextRef="c19" unitRef="usd">695218.0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f424" decimals="0" contextRef="c1" unitRef="usd">640685.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <dei:DocumentPeriodEndDate id="f425" contextRef="c1">2020-03-31</dei:DocumentPeriodEndDate>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="f426" decimals="0" contextRef="c1" unitRef="usd">38133.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="f427" decimals="0" contextRef="c134" unitRef="usd">240000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f428" decimals="0" contextRef="c59" unitRef="usd">223.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f429" decimals="0" contextRef="c60" unitRef="usd">963.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f430" decimals="INF" contextRef="c135" unitRef="usd1">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="f431" decimals="0" contextRef="c136" unitRef="usd">1281411.0</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:InvestmentOwnedAtFairValue id="f432" decimals="0" contextRef="c17" unitRef="usd">67000.0</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="f433" decimals="0" contextRef="c17" unitRef="usd">345131.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="f434" decimals="0" contextRef="c17" unitRef="usd">-891510.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f435" decimals="0" contextRef="c62" unitRef="usd">127.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <dei:EntityRegistrantName id="f436" contextRef="c1">Cannabis Sativa, Inc.</dei:EntityRegistrantName>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="f437" decimals="0" contextRef="c1" unitRef="usd">65500.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <cbds.com:StockPayable id="f438" decimals="0" contextRef="c56" unitRef="usd">532146.0</cbds.com:StockPayable>
  <us-gaap:PropertyPlantAndEquipmentNet id="f439" decimals="0" contextRef="c19" unitRef="usd">6440.0</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f440" decimals="0" contextRef="c26" unitRef="usd">454297.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="f441" decimals="0" contextRef="c26" unitRef="usd">-128.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:InterestPayableCurrent id="f442" decimals="0" contextRef="c137" unitRef="usd">87979.0</us-gaap:InterestPayableCurrent>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f443" decimals="0" contextRef="c63" unitRef="usd">40.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f444" decimals="INF" contextRef="c17" unitRef="usd1">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="f445" decimals="0" contextRef="c56" unitRef="usd">151946.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f446" decimals="0" contextRef="c65" unitRef="usd">639499.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:ProceedsFromRelatedPartyDebt id="f447" decimals="0" contextRef="c1" unitRef="usd">65500.0</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="f448" decimals="0" contextRef="c19" unitRef="usd">-840192.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:AssetsCurrent id="f449" decimals="0" contextRef="c17" unitRef="usd">424427.0</us-gaap:AssetsCurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="f450" decimals="INF" contextRef="c19" unitRef="usd1">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:InvestmentOwnedAtFairValue id="f451" decimals="0" contextRef="c19" unitRef="usd">48000.0</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f452" decimals="0" contextRef="c66" unitRef="usd">454130.0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f453" xsi:nil="true" contextRef="c68" unitRef="usd"/>
  <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets id="f454" decimals="INF" contextRef="c1" unitRef="shares">10000000.0</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="f455" decimals="0" contextRef="c26" unitRef="usd">0.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f456" xsi:nil="true" contextRef="c70" unitRef="usd"/>
  <us-gaap:AccountsReceivableNetCurrent id="f457" decimals="0" contextRef="c17" unitRef="usd">4581.0</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:PreferredStockSharesAuthorized id="f458" decimals="INF" contextRef="c17" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:InterestPayableCurrent id="f459" decimals="0" contextRef="c138" unitRef="usd">100767.0</us-gaap:InterestPayableCurrent>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f460" xsi:nil="true" contextRef="c72" unitRef="usd"/>
  <us-gaap:InventoryNet id="f461" decimals="0" contextRef="c17" unitRef="usd">64892.0</us-gaap:InventoryNet>
  <us-gaap:PreferredStockSharesAuthorized id="f462" decimals="INF" contextRef="c135" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
  <cbds.com:WarrantsExpire id="f463" decimals="INF" contextRef="c121" unitRef="shares">125000.0</cbds.com:WarrantsExpire>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f464" xsi:nil="true" contextRef="c73" unitRef="usd"/>
  <us-gaap:ProceedsFromRelatedPartyDebt id="f465" decimals="0" contextRef="c26" unitRef="usd">0.0</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f466" xsi:nil="true" contextRef="c75" unitRef="usd"/>
  <us-gaap:AssetsCurrent id="f467" decimals="0" contextRef="c19" unitRef="usd">394657.0</us-gaap:AssetsCurrent>
  <us-gaap:PreferredStockSharesAuthorized id="f468" decimals="INF" contextRef="c19" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets id="f469" decimals="0" contextRef="c1" unitRef="usd">200000.0</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f470" xsi:nil="true" contextRef="c78" unitRef="usd"/>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="f471" decimals="0" contextRef="c19" unitRef="usd">336107.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockSharesIssued id="f472" decimals="INF" contextRef="c19" unitRef="shares">22224199.0</us-gaap:CommonStockSharesIssued>
  <us-gaap:PrepaidExpenseOtherNoncurrent id="f473" decimals="0" contextRef="c17" unitRef="usd">0.0</us-gaap:PrepaidExpenseOtherNoncurrent>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f474" xsi:nil="true" contextRef="c79" unitRef="usd"/>
  <us-gaap:Investments id="f475" decimals="0" contextRef="c17" unitRef="usd">67000.0</us-gaap:Investments>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="f476" xsi:nil="true" contextRef="c81" unitRef="usd"/>
  <us-gaap:PreferredStockSharesIssued id="f477" decimals="INF" contextRef="c17" unitRef="shares">1254012.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="f478" decimals="0" contextRef="c57" unitRef="usd">44923.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:PreferredStockSharesOutstanding id="f479" decimals="INF" contextRef="c17" unitRef="shares">1254012.0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:Investments id="f480" decimals="0" contextRef="c19" unitRef="usd">48000.0</us-gaap:Investments>
  <us-gaap:InventoryNet id="f481" decimals="0" contextRef="c19" unitRef="usd">0.0</us-gaap:InventoryNet>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="f482" decimals="0" contextRef="c1" unitRef="usd">9024.0</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <cbds.com:ConversionOfPreferredToCommonValue id="f483" xsi:nil="true" contextRef="c1" unitRef="usd"/>
  <us-gaap:PrepaidExpenseCurrent id="f484" decimals="0" contextRef="c17" unitRef="usd">9823.0</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:PreferredStockSharesIssued id="f485" decimals="INF" contextRef="c19" unitRef="shares">1021849.0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="f486" contextRef="c1">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;2. &amp;#160;Property and Equipment &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment consisted of the following&#13;at March 31, 2020 and December 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; width: 55%; padding: 0.75pt 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; width: 22%; padding: 0.75pt 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;March 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; width: 23%; padding: 0.75pt 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; vertical-align: top; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right; vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;193,769&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right; vertical-align: top"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;17,414&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Leasehold Improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; vertical-align: bottom; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;2,500&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; vertical-align: top; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;2,500&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; vertical-align: top; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right; vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;196,269&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right; vertical-align: top"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;19,914&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less: &amp;#160;Accumulated Depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(13,791)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: top; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(13,474)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Net Property and Equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;182,478&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: top; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;6,440&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation expense for the three months ended&#13;March 31, 2020 and 2019 was $317 and $779, respectively.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:PrepaidExpenseOtherNoncurrent id="f487" decimals="0" contextRef="c19" unitRef="usd">50000.0</us-gaap:PrepaidExpenseOtherNoncurrent>
  <cbds.com:ConversionOfPreferredToCommonValue id="f488" xsi:nil="true" contextRef="c65" unitRef="usd"/>
  <cbds.com:OperatingLeaseLiabilityArisingFromAcquiringRightToUseAsset id="f489" decimals="0" contextRef="c1" unitRef="usd">21120.0</cbds.com:OperatingLeaseLiabilityArisingFromAcquiringRightToUseAsset>
  <cbds.com:WarrantsExpireDate id="f490" contextRef="c121">2022-11-30</cbds.com:WarrantsExpireDate>
  <us-gaap:CommonStockParOrStatedValuePerShare id="f491" decimals="INF" contextRef="c17" unitRef="usd1">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="f492" decimals="0" contextRef="c26" unitRef="usd">-107023.0</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <cbds.com:WarrantsExpire id="f493" decimals="INF" contextRef="c124" unitRef="shares">49900.0</cbds.com:WarrantsExpire>
  <cbds.com:ConversionOfPreferredToCommonValue id="f494" decimals="0" contextRef="c59" unitRef="usd">-80.0</cbds.com:ConversionOfPreferredToCommonValue>
  <cbds.com:SharesInEscrowDescription id="f495" contextRef="c1">Company has 419,475 shares of common stock in escrow as part of the acquisition of PrestoCorp. These shares are issuable in certain circumstances to the principals of PrestoCorp based on performance of the PrestoCorp business in 2020 and 2021.  The escrow account originally contained 629,213 shares of common stock but 209,738 shares were cancelled in 2018 when the performance requirements were not met.  The escrowed shares are not counted in the outstanding stock of the Company and will be considered compensation to the principals if and when issued. The escrow account also includes an additional 500 shares of PrestoCorp common stock which is distributable either back to the principals of PrestoCorp or to the Company, also depending on certain minimum performance requirements which extend into 2021.</cbds.com:SharesInEscrowDescription>
  <us-gaap:PrepaidExpenseCurrent id="f496" decimals="0" contextRef="c19" unitRef="usd">3999.0</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="f497" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;6. &amp;#160;Stockholders&amp;#8217; Equity&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Share Capital &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The authorized capital of the Company consists&#13;of 45,000,000 shares of Common Stock with a par value of $0.001 and 5,000,000 shares of preferred stock issuable in series with&#13;such rights, preferences and conditions as the Board of Directors may establish. &amp;#160;The Company has designated and established&#13;the rights of Series A preferred stock (&amp;#8220;Series A&amp;#8221;) with a par value of $0.001. &amp;#160;The Company is authorized to&#13;issue up to 5,000,000 shares of Series A. &amp;#160;The holders of Series A are entitled to dividends if the Company declares a dividend&#13;on common shares, have no liquidation preference, have voting rights equal to 1 vote per share, and can be converted into one share&#13;of common at any time. In the three months ended March 31, 2020, a related party converted 80,337 preferred shares into 80,337&#13;shares of common stock. No preferred shares were converted in the three months ended March 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Shares of Stock issued for Asset Acquisition&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In the three months ended March 31, 2020, the&#13;Company acquired assets and established GK Manufacturing and Packaging, Inc. (&amp;#8220;GKMP&amp;#8221;) to conduct contract manufacturing&#13;operations for customers seeking to obtain CBD infused products, including salves, tinctures, edibles, and other products containing&#13;CBD. In connection with the acquisition, the Company issued two key individuals an aggregate of 100,000 shares of common stock&#13;with a fair value of $109,000 for a 51% interest in GKMP. Assets acquired included inventory needed for manufacturing the CBD products,&#13;a packaging line, and other manufacturing equipment. The assets were valued at $213,725, of which $104,725 relates to the 49% non-controlling&#13;interest. GKMP also assumed the payments on a lease for equipment, agreed to provide up to $500,000 of additional working capital&#13;to GKMP, and agreed to an earnout provision where additional shares of common stock may become issuable to the key individuals&#13;in the event certain performance standards are met. See Note 7.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Upon completion of the acquisition of&#13;assets for GKMP, GKMP entered into employment agreements with the two key individuals. The employment agreements are&#13;terminable at any time with or without cause, but in the event of termination without cause, the salary will continue for six&#13;months. Salary for the president of GKMP is set at $65,000 per annum and salary for the Vice President &amp;#8211; Sales and&#13;Marketing is set at $50,000 per annum. The agreements also provide the individuals with expense reimbursements and other&#13;employee benefits comparable to those being offered to the other employees of the Company. Currently, GKMP has not&#13;established any other employee benefit programs. The 49% non-controlling interest is considered a related party to the&#13;Company because the non-controlling interest is owned, in part by the president of GKMP.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The completion of the GKMP asset acquisition&#13;resulted in payment of a finder&amp;#8217;s fee to an unrelated party. The finder&amp;#8217;s fee was paid by issuance of 50,000 shares&#13;of common stock with a fair value at the time of issuance of $36,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;2017 Stock Plan&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 28, 2017, the Company adopted the Cannabis&#13;Sativa 2017 Stock Plan which authorized the Company to utilize common stock to compensate employees, officers, directors, and independent&#13;contractors for services provided to the Company. The Company authorized up to 3,000,000 shares of common stock to be issued pursuant&#13;to the 2017 Stock Plan. At March 31, 2020, the Company was authorized to issue up to 954,720 additional shares under the 2017 Stock&#13;Plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At March 31, 2020 and December 31, 2019, the&#13;Company had outstanding warrants to purchase 125,000 shares and 174,900 shares of the Company&amp;#8217;s common stock, respectively.&#13;The exercise price on 125,000 warrants was $0.80 per share and these warrants expire in November 2022. The exercise price on 49,900&#13;warrants was $2.00 per share and these warrants expired February 1, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Securities Issuances for Acquisitions and&#13;Services&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended March 31, 2020, shares&#13;of common stock and preferred stock were issued to related and non-related parties for services. The following table breaks out&#13;the issuances by type of transaction and by related and non-related parties under the plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Three months ended March 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Acquistions&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Services&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; width: 24%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Related Parties&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Common&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Common&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Preferred&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Common&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Preferred&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;David Tobias, Officer, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;42,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;42,857&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Brad Herr, Officer, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;131,964&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;63,342&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;131,964&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;63,342&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Robert Tankson, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;84,326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;40,476&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;84,326&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;40,476&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Cathy Carroll, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;42,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;42,857&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Trevor Reed, Director&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,881&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;7,142&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,881&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;7,142&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total for related parties&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;320,457&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;196,674&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;320,457&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;196,674&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Related parties - acquistion&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;109,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;652,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;395,401&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;752,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;504,401&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Aggregate Totals&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;109,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;973,380&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;592,075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,073,380&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;89,286&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;701,075&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the three months ended March 31, 2020,&#13;David Tobias, Chief Executive Officer and Director, converted 80,337 shares of preferred stock into common stock in accordance&#13;with the terms of the preferred stock. No preferred shares were converted in the three months ended March 31, 2019&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended March 31, 2019, shares&#13;of common stock were issued to non-related parties. The following table breaks out the issuances by type of transaction and by&#13;related and non-related parties under the plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Three months ended March 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Services&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Common&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Preferred&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Unrelated parties issued&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;35,000 &lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;116,000 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Unrelated Parties Cancelled&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(70,000)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Aggregate Totals&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(35,000)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.25pt double; text-align: right; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;116,000 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Stock Payable&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At December 31, 2019, there was a balance of&#13;$640,685 in stock payable. The balance in stock payable at December 31, 2019 was paid through issuance of 223,214 preferred shares&#13;and 963,238 common shares of stock in the quarter ended March 31, 2020. Of these shares issued, 223,214 shares of preferred stock&#13;and 521,411 shares of common stock valued in the aggregate at $196,674 were issued to officers and directors of the Company. The&#13;balance in stock payable at March 31, 2020 was $0.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At December 31, 2018, there was a balance of&#13;$532,146 in stock payable. The balance in stock payable at December 31, 2018 was paid through issuance of 39,391 preferred shares&#13;and 127,061 common shares of stock in the quarter ended March 31, 2019. Of these shares issued, 39,391 shares of preferred stock&#13;and 85,681 shares of common stock, valued in the aggregate at $340,198 were issued to officers and directors of the Company.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:PreferredStockSharesOutstanding id="f498" decimals="INF" contextRef="c19" unitRef="shares">1021849.0</us-gaap:PreferredStockSharesOutstanding>
  <cbds.com:StockPayable id="f499" decimals="0" contextRef="c17" unitRef="usd">0.0</cbds.com:StockPayable>
  <us-gaap:CommitmentsAndContingencies id="f500" decimals="0" contextRef="c17" unitRef="usd">0.0</us-gaap:CommitmentsAndContingencies>
  <cbds.com:ConversionOfPreferredToCommonValue id="f501" decimals="0" contextRef="c60" unitRef="usd">80.0</cbds.com:ConversionOfPreferredToCommonValue>
  <cbds.com:WarrantsExpireDate id="f502" contextRef="c124">2020-02-01</cbds.com:WarrantsExpireDate>
  <cbds.com:ConversionOfPreferredToCommonValue id="f503" xsi:nil="true" contextRef="c68" unitRef="usd"/>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="f504" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;1. Organization and Summary of Significant Accounting Policies&lt;/b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Nature of Business:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cannabis Sativa, Inc. (the &amp;#8220;Company,&amp;#8221;&#13;&amp;#8220;us&amp;#8221;, &amp;#8220;we&amp;#8221; or &amp;#8220;our&amp;#8221;) was incorporated as Ultra Sun Corp. under the laws of Nevada in November&#13;2004. &amp;#160;On November 13, 2013, we changed our name to Cannabis Sativa, Inc. &amp;#160;&amp;#160; We operate through several subsidiaries&#13;including PrestoCorp, Inc. (&amp;#8220;PrestoCorp&amp;#8221;), iBudtender, Inc. (&amp;#8220;iBudtender&amp;#8221;), Wild Earth Naturals, Inc. (&amp;#8220;Wild&#13;Earth&amp;#8221;), Kubby Patent and Licenses Limited Liability Company, (&amp;#8220;KPAL&amp;#8221;), Hi Brands, International, Inc. (&amp;#8220;Hi&#13;Brands&amp;#8221;), GK Manufacturing and Packaging, Inc. (&amp;#8220;GKMP&amp;#8221;), and Eden Holdings LLC (&amp;#8220;Eden&amp;#8221;). &amp;#160;PrestoCorp&#13;and GK Manufacturing are both 51% owned subsidiaries and iBudtender is a 50.1% owned subsidiary. Wild Earth, KPAL, Hi Brands, and&#13;Eden are wholly owned subsidiaries. Currently, PrestoCorp, GKMP and iBudtender are operating subsidiaries, although iBudtender&#13;is not currently generating any revenue. The Company is reviewing opportunities for business development relating to Wild Earth,&#13;KPAL, and Hi Brands. Eden is not operating and had no activity for the three months ended March 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our primary operations in the three months&#13;ended March 31, 2020 were through PrestoCorp, which provides telemedicine online referral services for customers desiring medical&#13;marijuana cards in states where medical marijuana has been legalized. GKMP commenced operations during the quarter ended March&#13;31, 2020. The Company is also actively seeking new business opportunities for acquisition and is continually reviewing opportunities&#13;for product and brand development through our Wild Earth, Hi Brands, and KPAL subsidiaries. iBudtender is also working to complete&#13;and commercialize an application (the iBudtender App) that will provide a convenient means for sharing information about cannabis&#13;products, patients and businesses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Basis of Presentation:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fiscal year end is December 31. The accompanying&#13;condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019, have been prepared in accordance with accounting&#13;principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;) for interim financial information and&amp;#160;accordingly,&#13;they do not include all of the information and footnotes required by GAAP for complete financial statements.&amp;#160;In the opinion&#13;of the Company&amp;#8217;s management all material adjustments (consisting only of normal recurring adjustments) which are considered&#13;necessary for a fair presentation of the interim financial statements have been included. &amp;#160;Operating results for the three&#13;months ended March 31, 2020 are not necessarily indicative of the results of operations expected for the year ending December 31,&#13;2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The interim financial statements should be&#13;read in conjunction with the audited financial statements and related footnotes set forth in our annual report filed on Form 10-K&#13;for the year ended December 31, 2019 as filed with the United States Securities and Exchange Commission on May 14, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Principles of Consolidation:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The condensed consolidated financial statements&#13;include the accounts of Cannabis Sativa, Inc., and its wholly-owned subsidiaries; Wild Earth Naturals, Inc., Hi-Brands International,&#13;Inc., Eden Holdings LLC, our 50.1% ownership of iBudtender Inc., our 51% ownership of PrestoCorp, and our 51% ownership of GK Manufacturing&#13;Inc., (collectively referred to as the &amp;#8220;Company&amp;#8221;). &amp;#160;All significant inter-company balances have been eliminated&#13;in consolidation. We hold controlling interests in iBudTender, PrestoCorp and GK Manufacturing and exercise control through management&#13;practices and oversight by the Company&amp;#8217;s Board of Directors. GK Manufacturing was established in February 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Non-controlling Interests:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Non-controlling interests are portions of entities&#13;included in the condensed consolidated financial statements that are not attributable to the Company. Non-controlling interest&#13;are identified separately from the Company&amp;#8217;s stockholders&amp;#8217; equity and its net income (loss). Non-controlling interest&#13;equity balances include the non-controlling entity&amp;#8217;s initial contribution at the date of the original acquisition, ongoing&#13;contributions, distributions, and percentage share of earnings since inception. The non-controlling interests are calculated based&#13;on percentages of ownership.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Going Concern:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has an accumulated deficit of $75,471,554&#13;at March 31, 2020, which, among other factors, raises substantial doubt about the Company&amp;#8217;s ability to continue as a going&#13;concern. The ability of the Company to continue as a going concern is dependent on the Company&amp;#8217;s ability to generate profitable&#13;operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from&#13;normal business operations when they are due.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Use of Estimates:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of financial statements in&#13;conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated&#13;financial statements and accompanying notes. &lt;font style="color: #212529"&gt;Significant estimates and assumptions by management affect&#13;the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), the provision&#13;for income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, and the value&#13;attributed to stock-based awards.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Accounts Receivable:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We estimate credit loss reserves for&#13;accounts receivable on an individual receivable basis. A specific allowance reserve is established based on expected future&#13;cash flows and the financial condition of the debtor.&amp;#160;&amp;#160;We charge off customer balances in part or in full when it&#13;is more likely than not that we will not collect that amount of the balance due.&amp;#160;&amp;#160;We consider any balance unpaid&#13;after the contract payment period to be past due.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Inventories:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventory costs, when applicable, include those&#13;costs directly attributable to the manufacture of the product before sale. Inventory consists of raw materials and finished goods&#13;and is carried at the lower of cost or net realizable value, using the first-in, first-out method of determining cost. &amp;#160;As&#13;of March 31, 2020, the Company had $64,892 in inventory relating to GKMP. Inventory consists of the raw materials and packaging&#13;used to manufacture CBD infused products for our customers. As of December 31, 2019, the Company had no inventory.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Property and Equipment:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment are recorded at cost.&#13;&amp;#160;Depreciation is provided for on the straight-line method over the estimated useful lives of the assets. &amp;#160;The average&#13;lives range from five (5) to ten (10) years. &amp;#160;Leasehold improvements are amortized on the straight-line method over the lesser&#13;of the lease term or the useful life. Maintenance and repairs that neither materially add to the value of the property nor appreciably&#13;prolong its life are charged to expense as incurred. &amp;#160;Betterments or renewals are capitalized when incurred. &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Fair Value of Financial Instruments:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The carrying amounts of&amp;#160;cash and cash&#13;equivalents and amounts due to related parties approximate fair value given their short-term nature.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Cash:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash is held at major financial institutions&#13;and insured by the Federal Deposit Insurance Corporation (FDIC) up to federal insurance limits. The Company considers all highly&#13;liquid investments purchased with an original maturity of three months or less when acquired to be cash equivalents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Net Loss per Share:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Net loss per share is computed by dividing&#13;net loss available to common shareholders by the weighted average number of common shares outstanding for the period and contains&#13;no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings&#13;of the Company. &amp;#160;Potentially dilutive shares are excluded from the calculation of diluted net loss per share because the&#13;effect is anti-dilutive. At March 31, 2020 and March 31, 2019 the Company had 125,000 and 49,900 outstanding warrants, respectively,&#13;that would be dilutive to future periods net income. Also, at March 31, 2020 and March 31, 2019 the Company had 1,254,012 and&#13;798,835 shares of convertible Series A preferred stock, respectively, that would be dilutive to future periods net income. See&#13;Note 6.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Revenue Recognition: &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenues are recognized when control of the&#13;promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects&#13;to receive in exchange for those goods or services. The Company recognizes revenue from the sale of products and services in accordance&#13;with ASC 606,&amp;#8221; Revenue &lt;i&gt;Recognition&lt;/i&gt;&amp;#8221;. The Company applies the following five steps in order to determine the&#13;appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 8%"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 92%"&gt;&lt;font style="font-size: 10pt"&gt;identify the contract with a customer;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;identify the performance obligations in the contract;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;determine the transaction price;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;allocate the transaction price to performance obligations in the contract; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#149;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;recognize revenue as the performance obligation is satisfied.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Provision for sales incentives, discounts and&#13;returns and allowances, if applicable, are accounted for as reductions of revenue in the period the related sales are recorded.&#13;The Company had no warranty costs associated with the sales of its products in the periods presented in the accompanying Consolidated&#13;Statements of Operations and no provision for warranty expenses has been included.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;The Company generates revenue&#13;based on a per telehealth visit basis for clients looking to obtain a permit to use marijuana for medical purposes in states that&#13;have legalized medical marijuana. Revenues are recognized when the Company satisfies its performance obligation to stand ready&#13;to provide telehealth services. This occurs at the same time an online client subscribes for the visit and gains access to our&#13;network of health care professionals. The billing and payment processes are automated through our online platform. Revenue is recognized&#13;in an amount that reflects the consideration that is received in exchange for the service.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;With the recent addition of&#13;GKMP, the Company will also be reporting revenue from manufacturing operations in future periods. The Company will recognize revenue&#13;from manufacturing operations when manufacturing and packaging processes are complete, and the products are shipped to the customer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In the quarter ended March 31, 2020, the Company&#13;operated as one reportable segment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Investments&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Investments in equity securities&#13;that are less than 20% owned are stated at fair value. The Company recognizes unrealized holding gains and losses in other (Income)&#13;Expenses in the condensed consolidated statement of operations. On disposal of an investment, the difference between the disposal&#13;proceeds and the carrying amount is recognized as income or loss on the condensed consolidated statement of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Intangible Assets and Goodwill:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We account for intangible assets and goodwill&#13;in accordance with ASC 350 &lt;i&gt;&amp;#8220;Intangibles-Goodwill and Other&amp;#8221;&lt;/i&gt; (&amp;#8220;ASC 350&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Intangible asset amounts represent&#13;the acquisition date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined&#13;by using the income approach, discounting projected future cash flows based on management&amp;#8217;s expectations of the current and&#13;future operating environment. The rates used to discount projected future cash flows reflected a weighted average cost of capital&#13;based on our industry, capital structure and risk premiums including those reflected in the current market capitalization. Definite-lived&#13;intangible assets are amortized over their useful lives, which have historically ranged from 5 to 10 years. The carrying amounts&#13;of our definite-lived intangible assets are evaluated for recoverability whenever events or changes in circumstances indicate that&#13;the entity may be unable to recover the asset&amp;#8217;s carrying amount. We do not have any indefinite-lived intangible assets recorded&#13;from acquisitions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Goodwill represents the excess&#13;of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill&#13;is not amortized but is tested for impairment annually or more frequently if events or changes in circumstances indicate that the&#13;asset may be impaired. The fair value of the reporting unit is evaluated on qualitative factors to determine if the reported value&#13;may be impaired. If the qualitative factors indicate a likelihood of impairment, we then evaluate carrying value of the reporting&#13;unit based on quantitative factors using the income approach. An impairment charge is recognized for the excess of the carrying&#13;value of goodwill for the reporting unit over its implied fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; color: #212529"&gt;&amp;#8203;&amp;#8203;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Advertising Expense:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Advertising costs are expensed&#13;as incurred and are included in general and administrative expense in the accompanying consolidated statements of operations. Advertising&#13;costs were $87,088 and $33,153 for the three months ended March 31, 2020 and 2019, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Stock-Based Compensation:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -45pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Stock-based payments to employees&#13;and non-employees are recognized at their fair values.&amp;#160;&amp;#160;Compensation expense is recognized over the period during which&#13;an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting&#13;period). The Company uses the Black-Scholes option pricing model when necessary as the most appropriate fair value method for&#13;option awards. Most awards have been in the form of shares of the Company&amp;#8217;s common and preferred stock issued under the&#13;Company&amp;#8217;s 2017 Stock Plan. See Note 6. The Company currently recognizes compensation costs immediately as our awards are&#13;100% vested at the time of issuance.&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Income Taxes:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;The Company utilizes the liability&#13;method of accounting for income taxes which requires that deferred tax assets and liabilities be recorded to reflect the future&#13;tax consequences of temporary differences between the book and tax basis of various assets and liabilities.&amp;#160;&amp;#160;Deferred&#13;tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those&#13;temporary differences are expected to be recovered or settled. Additionally, deferred tax assets are evaluated, and a valuation&#13;allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. There&#13;can be no assurance that the Company&amp;#8217;s future operations will produce sufficient earnings so that the deferred tax asset&#13;can be fully utilized. The Company currently maintains a full valuation allowance against net deferred tax assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Leases:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;The Company determines if an&#13;arrangement is a lease, or contains a lease, at the inception of an arrangement. If the Company determines that the arrangement&#13;is a lease, or contains a lease, at lease inception, it then determines whether the lease is an operating lease or finance lease.&#13;Operating and finance leases result in recording a right-of-use (&amp;#8220;ROU&amp;#8221;) asset and lease liability on the consolidated&#13;balance sheets. ROU assets represent the Company&amp;#8217;s right to use an underlying asset for the lease term and lease liabilities&#13;represent the Company&amp;#8217;s obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities&#13;are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating&#13;operating lease ROU assets and operating lease liabilities, the Company uses the non-cancellable lease term plus options to extend&#13;that it is reasonably certain to exercise. Lease expense for operating lease payments is recognized on a straight-line basis over&#13;the lease term. The Company&amp;#8217;s leases generally do not provide an implicit rate. As such, the Company uses its incremental&#13;borrowing rate based on the information available at commencement date in determining the present value of lease payments. The&#13;Company has elected not to recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for&#13;any class of underlying asset. The Company has elected not to separate lease and non-lease components for any class of underlying&#13;asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Recent Accounting Pronouncements:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Accounting Standards Updates Adopted&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;In January 2017, the&#13;FASB issued ASU 2017-04,&amp;#160;Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The&#13;update simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill&#13;impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit&amp;#8217;s&#13;goodwill with the carrying amount. This update is effective for annual and interim periods beginning after December 15, 2019,&#13;and interim periods within that reporting period. The adoption of the new guidance on January 1, 2020 did not have a material&#13;impact on the Company&amp;#8217;s&amp;#160;consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;In August 2018, the FASB issued&#13;ASU No. 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value&#13;Measurement. The update removes, modifies, and makes additions to the disclosure requirements on fair value measurements. The update&#13;was adopted as of January 1, 2020, and its adoption did not have a material impact on the Company&amp;#8217;s financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Accounting Standards Updates to Become Effective&#13;in Future Periods&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;In December 2019, the FASB&#13;issued ASU No. 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The update contains a number of provisions&#13;intended to simplify the accounting for income taxes. The update is effective for fiscal years beginning after December 15, 2020,&#13;with early adoption permitted. Management is evaluating the impact of this update on the Company&amp;#8217;s financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Other accounting standards&#13;that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material&#13;impact on the financial statements upon adoption.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;When required to measure assets&#13;or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding&#13;the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their&#13;entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to&#13;the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant&#13;other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period&#13;are included in earnings&amp;#160;that are attributable to the change in unrealized gains or losses relating to those assets and liabilities&#13;still held at the reporting date. We measure our investment in equity securities at fair value on a recurring basis.&amp;#160;&amp;#160;The&#13;Company&amp;#8217;s equity securities are valued using inputs observable in active markets and are therefore classified as Level 1&#13;within the fair value hierarchy.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <cbds.com:CommonStockIssuedForStockPayable id="f505" decimals="0" contextRef="c1" unitRef="usd">640685.0</cbds.com:CommonStockIssuedForStockPayable>
  <us-gaap:AccountsReceivableNetCurrent id="f506" decimals="0" contextRef="c19" unitRef="usd">4551.0</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:CommonStockSharesAuthorized id="f507" decimals="INF" contextRef="c17" unitRef="shares">45000000.0</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="f508" decimals="0" contextRef="c17" unitRef="usd">-75471554.0</us-gaap:RetainedEarningsAccumulatedDeficit>
  <cbds.com:ConversionOfPreferredToCommonValue id="f509" xsi:nil="true" contextRef="c72" unitRef="usd"/>
  <cbds.com:OperatingLeaseLiabilityArisingFromAcquiringRightToUseAsset id="f510" decimals="0" contextRef="c26" unitRef="usd">0.0</cbds.com:OperatingLeaseLiabilityArisingFromAcquiringRightToUseAsset>
  <us-gaap:CommonStockParOrStatedValuePerShare id="f511" decimals="INF" contextRef="c19" unitRef="usd1">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <cbds.com:StockPayable id="f512" decimals="0" contextRef="c19" unitRef="usd">640685.0</cbds.com:StockPayable>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="f513" decimals="0" contextRef="c1" unitRef="usd">-667327.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <cbds.com:ConversionOfPreferredToCommonValue id="f514" xsi:nil="true" contextRef="c75" unitRef="usd"/>
  <us-gaap:LiabilitiesAndStockholdersEquity id="f515" decimals="0" contextRef="c17" unitRef="usd">3230377.0</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:CommitmentsAndContingencies id="f516" decimals="0" contextRef="c19" unitRef="usd">0.0</us-gaap:CommitmentsAndContingencies>
  <cbds.com:NetAssetAcquisitionAcquiredWithSharesOfCommonStock id="f517" decimals="0" contextRef="c1" unitRef="usd">213725.0</cbds.com:NetAssetAcquisitionAcquiredWithSharesOfCommonStock>
  <cbds.com:CommonStockIssuedForStockPayable id="f518" decimals="0" contextRef="c26" unitRef="usd">454296.0</cbds.com:CommonStockIssuedForStockPayable>
  <us-gaap:CommonStockSharesOutstanding id="f519" decimals="INF" contextRef="c17" unitRef="shares">24341154.0</us-gaap:CommonStockSharesOutstanding>
  <cbds.com:ConversionOfPreferredToCommonValue id="f520" xsi:nil="true" contextRef="c81" unitRef="usd"/>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f521" decimals="0" contextRef="c1" unitRef="usd">213725.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock id="f522" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;3. &amp;#160;Intangibles and Goodwill&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all intangibles to be&#13;definite-lived assets with lives of 5 to 10 years. Intangibles consisted of the following at March 31, 2020 and December 31, 2019:&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 4in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; width: 59%; padding: 0.75pt 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; width: 19%; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;March 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; width: 22%; padding: 0.75pt 5.4pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;CBDS.com website (Cannabis Sativa)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;13,999&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;13,999&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Intellectual Property Rights (PrestoCorp)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;240,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;240,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Patents and Trademarks (KPAL)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;1,281,411&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;1,281,411&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total Intangibles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;1,535,410&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;1,535,410&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less: &amp;#160;Accumulated Amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(891,510)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(840,192)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Net Intangible Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;643,900&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;695,218&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization expense for the three months ended&#13;March 31, 2020 and 2019 was $51,318 and $139,739, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization of intangibles for each of the&#13;next five years is:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; width: 84%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; width: 16%"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;196,239&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;167,323&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;159,321&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;$&amp;#9;121,017&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill in the amount of $3,010,202 was recorded&#13;as part of the acquisition of PrestoCorp that occurred on August 1, 2017. Cumulative impairment of the PrestoCorp goodwill totals&#13;$1,173,000 as of March 31, 2020 and December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill in the amount of $336,667 was recorded&#13;as part of the acquisition of iBudtender that occurred on August 8, 2016. For the year ended December 31, 2019 the Company recorded&#13;a&amp;#160;$336,667 impairment of the iBudtender goodwill. The impairment of the iBudtender goodwill was due to delays in completion&#13;of the iBudTender software and mobile app, and failure to commence viable business operations, as well as the uncertainty surrounding&#13;the future of the business opportunity. Cumulative impairment of the iBudTender goodwill totals $336,667 as of March 31, 2020&#13;and December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There were no additions, deletions, and impairments&#13;recognized in the three months ended March 31, 2020 and 2019.&lt;/p&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
  <us-gaap:CommonStockSharesIssued id="f523" decimals="INF" contextRef="c17" unitRef="shares">24341154.0</us-gaap:CommonStockSharesIssued>
  <us-gaap:NonoperatingIncomeExpense id="f524" decimals="0" contextRef="c1" unitRef="usd">5448.0</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:CommonStockSharesAuthorized id="f525" decimals="INF" contextRef="c19" unitRef="shares">45000000.0</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:MinorityInterest id="f526" decimals="0" contextRef="c17" unitRef="usd">1212427.0</us-gaap:MinorityInterest>
  <cbds.com:NetAssetAcquisitionAcquiredWithSharesOfCommonStock id="f527" decimals="0" contextRef="c26" unitRef="usd">0.0</cbds.com:NetAssetAcquisitionAcquiredWithSharesOfCommonStock>
  <us-gaap:LiabilitiesAndStockholdersEquity id="f528" decimals="0" contextRef="c19" unitRef="usd">2981517.0</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f529" decimals="0" contextRef="c65" unitRef="usd">108900.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockholdersEquity id="f530" decimals="0" contextRef="c17" unitRef="usd">727485.0</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f531" xsi:nil="true" contextRef="c59" unitRef="usd"/>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="f532" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;7. &amp;#160;Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Leases.&lt;/i&gt; The Company renewed a lease&#13;in Mesquite, Nevada in November 2019 on a month to month basis at a cost of $600 per month. The Company terminated the lease at&#13;the end of February 2020, and now operates out of a virtual office maintained by our Chief Executive Officer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;PrestoCorp leases office space through WeWork&#13;in New York for $2,444 per month on a month to month arrangement. Until February 2019, PrestoCorp also leased space in San Francisco&#13;for $2,800 per month. PrestoCorp terminated its lease and closed its office in San Francisco as of the end of February 2019. Primary&#13;operations for PrestoCorp are now based in New York City. Rent expense for PrestoCorp for the three months ended March 31, 2020&#13;and 2019 was $7,322 and $8,044, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;GKMP leases a commercial printer used in its&#13;manufacturing and packaging operations. The Company assumed the lease as part of the acquisition of GKMP&amp;#8217;s assets (see Note&#13;6). On the date it was assumed, the Company recognized an operating lease liability and a right of use asset of $23,286. To calculate&#13;the liability and right of use asset, the Company utilized a 10% incremental borrowing rate to discount the future rent payments&#13;of $683 per month over the remaining lease term of 40 months. For the quarter ended March 31, 2020, the Company recognized $683&#13;in rent expense in the consolidated statements of operations. At March 31, 2020, the remaining lease term is 39 months. The lessor&#13;holds a deposit of $1,250 on the lease. Future minimum lease payments over the remaining term are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt; width: 78%"&gt;&lt;font style="font-size: 10pt"&gt;Nine months ended December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right; width: 22%"&gt;&lt;font style="font-size: 10pt"&gt;$&amp;#9;6,143&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Twelve months ended December 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;8,190&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Twelve months ended December 31, 2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;8,190&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Six months ended June 30, 2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;4,095&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-top: black 1pt solid; text-align: right; padding: 0.75pt -73.5pt 0.75pt 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;26,618&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Less imputed interest&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; padding: 0.75pt -73.5pt 0.75pt 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(5,498)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Net lease liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding: 0.75pt -73.5pt 0.75pt 0.75pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;21,120&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Current portion&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; padding: 0.75pt -73.5pt 0.75pt 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9;(6,498)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding: 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;Long term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; padding: 0.75pt -73.5pt 0.75pt 0.75pt"&gt;&lt;font style="font-size: 10pt"&gt;$&amp;#9;14,622&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Litigation.&lt;/i&gt; In the ordinary course of&#13;business, we may face various claims brought by third parties and we may, from time to time, make claims or take legal actions&#13;to assert our rights, including intellectual property disputes, contractual disputes and other commercial disputes. Any of these&#13;claims could subject us to litigation. As of March 31, 2020, one claim was pending or threatened relating to general business disputes&#13;and accounts payable for services. Management believes the outcome of currently pending claim is not likely to have a material&#13;effect on our consolidated financial position and results of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Shares in Escrow.&lt;/i&gt; At March 31,&#13;2020 and December 31, 2019, the Company has 419,475 shares of common stock in escrow as part of the acquisition of&#13;PrestoCorp. These shares are issuable in certain circumstances to the principals of PrestoCorp based on performance of the&#13;PrestoCorp business in 2020 and 2021. The escrow account originally contained 629,213 shares of common stock but 209,738&#13;shares were cancelled in 2018 when the performance requirements were not met. The escrowed shares are not counted in the&#13;outstanding stock of the Company and will be considered compensation to the principals if and when issued. The escrow account&#13;also includes an additional 500 shares of PrestoCorp common stock which is distributable either back to the principals of&#13;PrestoCorp or to the Company, also depending on certain minimum performance requirements which extend into 2021. If all of&#13;the PrestoCorp shares are ultimately distributed to the Company, the shares would have the effect of increasing the&#13;Company&amp;#8217;s ownership of PrestoCorp to 61% from the current level of 51%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Contingent Consideration.&lt;/i&gt; In connection&#13;with the GKMP asset acquisiton, the Company agreed to pay additional consideration to the two key individuals employed by GKMP&#13;upon achievement of certain performance goals. If GKMP net revenues exceed $3,000,000 and net income exceeds 25% of net revenues&#13;in the year ended December 31, 2020, an additional $1,000,000 in consideration will be due to the key individuals. If GKMP net&#13;revenues exceed $6,000,000 and net income exceeds 25% of net revenues in the year ended December 31, 2020, an additional $500,000&#13;in consideration will be due to the key individuals ($1,500,000 in the aggregate). This amount is payable in stock at the average&#13;closing price of the shares in the five trading days prior to the date of payment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Working Capital Obligation.&lt;/i&gt; In connection&#13;with the GKMP asset acquisition, the Company agreed to provide up to an additional $500,000 in working capital to GKMP. These amounts&#13;are recorded as investment in GKMP by CBDS and as equity on the books of GKMP and are eliminated in the consolidation. Due to the&#13;ownership structure of GKMP, 49% of the working capital payments from the Company to GKMP benefit the holders of the non-controlling&#13;interest.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CommonStockSharesOutstanding id="f533" decimals="INF" contextRef="c19" unitRef="shares">22224199.0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="f534" decimals="0" contextRef="c26" unitRef="usd">-748658.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock id="f535" contextRef="c1">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;4.&amp;#160;&amp;#160;Related Party Transactions&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has received advances from related&#13;parties and officers of the Company to cover operating expenses. Related parties include the officers and directors of the Company,&#13;and a significant shareholder holding in excess of a 10% interest in the Company. As of March 31, 2020, and December 31, 2019,&#13;amounts due to the related parties were $1,084,020 and $1,018,520, respectively. During the three months ended March 31, 2020 and&#13;2019, the Company recorded interest expense related to these advances at the rates between 5% and 8% per annum and in the amount&#13;of $13,552 and $10,843, respectively. The Company does not have written notes payable for these balances but has a verbal understanding&#13;with the related parties that written notes will be created in 2020 to reflect the balances due and payable December 31, 2025.&#13;At March 31, 2020 and December 31, 2019, there was $100,767 and $87,979, respectively, of accrued interest on these advances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At March 31, 2020 and December 31, 2019, the&#13;Company had a note payable to the founder of iBudtender of $10,142 and $10,142, respectively, which is included in due to related&#13;parties on the consolidated balance sheets. The note earns interest at 0% and was due on December 2019. The note has not yet been&#13;paid pending further review of the iBudtender business and adjustment of the agreements between the parties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the three months ended March 31, 2020&#13;and 2019, the Company incurred approximately $45,000 and $17,000, respectively, for consulting services from a nephew of the Company&amp;#8217;s&#13;president. These services were paid in shares of the Company&amp;#8217;s common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the three months ended March 31, 2020&#13;and 2019, the Company paid officer and director compensation for services in shares of common stock in order to reduce operating&#13;cash flow requirements. The shares were recorded at fair value at the time of issuance as compensation expense. See Note 6 regarding&#13;shares issued to related parties. These amounts totaled $196,674 and $0 at March 31, 2020 and March 31, 2019, respectively. The&#13;amounts are included in the statements of operations in general and administrative expenses.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:MinorityInterest id="f536" decimals="0" contextRef="c19" unitRef="usd">1158622.0</us-gaap:MinorityInterest>
  <us-gaap:OperatingIncomeLoss id="f537" decimals="0" contextRef="c1" unitRef="usd">-672775.0</us-gaap:OperatingIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions id="f538" decimals="0" contextRef="c60" unitRef="usd">100.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:NonoperatingIncomeExpense id="f539" decimals="0" contextRef="c26" unitRef="usd">-10843.0</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:StockholdersEquity id="f540" decimals="0" contextRef="c19" unitRef="usd">2132.0</us-gaap:StockholdersEquity>
</xbrli:xbrl>
